DANA-FARBER CANCER INSTITUTE: Form 990, tax year 2023

View the entire original 990 at ProPublica ↗

Organization: DANA-FARBER CANCER INSTITUTE (EIN 04-2263040)
Tax period: 2023-10-01 to 2024-09-30
Filed: 2025-08-11
IRS object ID: 202532239349300228
Schema version: 2023v6.0
Source: Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header
Form 990
Schedule A
Schedule B
Schedule C
Schedule D
Schedule F
Schedule G
Schedule H
Schedule I
Schedule J
Schedule K
Schedule K
Schedule L
Schedule M
Schedule O
Schedule R

Return header ReturnHeader

Field	Value	IRS element (for citing)
Return	2025-08-11T08:39:33+00:00	ReturnTs
Tax Period End	2024-09-30	TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

Field	Value	IRS element (for citing)
Preparer Firm EIN	346565596	PreparerFirmEIN

Preparer Firm Name PreparerFirmName

Field	Value	IRS element (for citing)
Business Name Line1	ERNST & YOUNG US LLP	BusinessNameLine1Txt

Preparer US Address PreparerUSAddress

Field	Value	IRS element (for citing)
Address Line1	200 CLARENDON STREET	AddressLine1Txt
City	BOSTON	CityNm
State Abbreviation	MA	StateAbbreviationCd
ZIP	021165072	ZIPCd

Field	Value	IRS element (for citing)
Return Type	990	ReturnTypeCd
Tax Period Begin	2023-10-01	TaxPeriodBeginDt

Filer Filer

Field	Value	IRS element (for citing)
EIN	042263040	EIN

Business Name BusinessName

Field	Value	IRS element (for citing)
Business Name Line1	Dana-Farber Cancer Institute Inc	BusinessNameLine1Txt

Field	Value	IRS element (for citing)
Business Name Control	DANA	BusinessNameControlTxt
Phone	6176323000	PhoneNum

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	450 BROOKLINE AVENUE BP418	AddressLine1Txt
City	BOSTON	CityNm
State Abbreviation	MA	StateAbbreviationCd
ZIP	02215	ZIPCd

Business Officer BusinessOfficerGrp

Field	Value	IRS element (for citing)
Person	MICHAEL L RENEY	PersonNm
Person Title	CFO & ASSISTANT TREASURER	PersonTitleTxt
Phone	6176323000	PhoneNum
Signature	2025-08-11	SignatureDt
Discuss With Paid Preparer	Yes (true)	DiscussWithPaidPreparerInd

Preparer Person PreparerPersonGrp

Field	Value	IRS element (for citing)
Preparer Person	George Pagano	PreparerPersonNm
PTIN	P01978122	PTIN
Phone	6172662000	PhoneNum
Preparation	2025-08-06	PreparationDt

Field	Value	IRS element (for citing)
Tax	2023	TaxYr
Build TS	2025-03-06 01:10:19Z	BuildTS

Form 990 IRS990

Principal Ofcr Business Name PrincipalOfcrBusinessName

Field	Value	IRS element (for citing)
Business Name Line1	BENJAMIN EBERT MD PHD PRESIDENT	BusinessNameLine1Txt

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	450 BROOKLINE AVENUE BP418	AddressLine1Txt
City	BOSTON	CityNm
State Abbreviation	MA	StateAbbreviationCd
ZIP	02215	ZIPCd

Field	Value	IRS element (for citing)
Gross Receipts	$3,475,402,876	GrossReceiptsAmt
Group Return For Affiliates	false	GroupReturnForAffiliatesInd
Organization501c3	Yes (X)	Organization501c3Ind
Website Address	WWW.DANA-FARBER.ORG	WebsiteAddressTxt
Type Of Organization Corp	Yes (X)	TypeOfOrganizationCorpInd
Formation	1951	FormationYr
Legal Domicile State	MA	LegalDomicileStateCd
Activity Or Mission	SEE SCHEDULE O	ActivityOrMissionDesc
Voting Members Governing Body	65	VotingMembersGoverningBodyCnt
Voting Members Independent	64	VotingMembersIndependentCnt
Total Employee	9211	TotalEmployeeCnt
Total Volunteers	500	TotalVolunteersCnt
Total Gross UBI	$41,707	TotalGrossUBIAmt
Net Unrelated Bus Txbl Incm	$24,555	NetUnrelatedBusTxblIncmAmt
PY Contributions Grants	$761,032,475	PYContributionsGrantsAmt
CY Contributions Grants	$779,153,701	CYContributionsGrantsAmt
PY Program Service Revenue	$2,278,805,851	PYProgramServiceRevenueAmt
CY Program Service Revenue	$2,611,491,064	CYProgramServiceRevenueAmt
PY Investment Income	$4,887,533	PYInvestmentIncomeAmt
CY Investment Income	$5,694,108	CYInvestmentIncomeAmt
PY Other Revenue	$342,861,910	PYOtherRevenueAmt
CY Other Revenue	$75,255,837	CYOtherRevenueAmt
PY Total Revenue	$3,387,587,769	PYTotalRevenueAmt
CY Total Revenue	$3,471,594,710	CYTotalRevenueAmt
PY Grants And Similar Paid	$8,080,255	PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid	$7,580,997	CYGrantsAndSimilarPaidAmt
PY Benefits Paid To Members	$0	PYBenefitsPaidToMembersAmt
CY Benefits Paid To Members	$0	CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid	$948,622,406	PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid	$1,082,475,984	CYSalariesCompEmpBnftPaidAmt
PY Total Prof Fndrsng Expns	$5,540,361	PYTotalProfFndrsngExpnsAmt
CY Total Prof Fndrsng Expns	$5,632,350	CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense	$50,705,899	CYTotalFundraisingExpenseAmt
PY Other Expenses	$2,040,560,837	PYOtherExpensesAmt
CY Other Expenses	$2,262,455,426	CYOtherExpensesAmt
PY Total Expenses	$3,002,803,859	PYTotalExpensesAmt
CY Total Expenses	$3,358,144,757	CYTotalExpensesAmt
PY Revenues Less Expenses	$384,783,910	PYRevenuesLessExpensesAmt
CY Revenues Less Expenses	$113,449,953	CYRevenuesLessExpensesAmt
Total Assets BOY	$4,735,245,065	TotalAssetsBOYAmt
Total Assets EOY	$5,348,876,627	TotalAssetsEOYAmt
Total Liabilities BOY	$1,374,670,226	TotalLiabilitiesBOYAmt
Total Liabilities EOY	$1,437,795,236	TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY	$3,360,574,839	NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY	$3,911,081,391	NetAssetsOrFundBalancesEOYAmt
Mission	SEE SCHEDULE O	MissionDesc
Significant New Program Srvc	false	SignificantNewProgramSrvcInd
Significant Change	false	SignificantChangeInd
Expense	$2,230,485,829	ExpenseAmt
Grant	$0	GrantAmt
Revenue	$2,611,491,064	RevenueAmt
Desc	CLINICAL CARE - SEE SCHEDULE O	Desc

Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp

Field	Value	IRS element (for citing)
Expense	$802,568,927	ExpenseAmt
Grant	$0	GrantAmt
Revenue	$0	RevenueAmt
Desc	RESEARCH - SEE SCHEDULE O	Desc

Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp

Field	Value	IRS element (for citing)
Expense	$43,367,218	ExpenseAmt
Grant	$7,580,997	GrantAmt
Revenue	$0	RevenueAmt
Desc	COMMUNITY BENEFITS - SEE SCHEDULE O	Desc

Field	Value	IRS element (for citing)
Total Program Service Expenses	$3,076,421,974	TotalProgramServiceExpensesAmt
Described In Section501c3	Yes (true)	DescribedInSection501c3Ind
Schedule B Required	Yes (true)	ScheduleBRequiredInd
Political Campaign Acty	false	PoliticalCampaignActyInd
Lobbying Activities	Yes (true)	LobbyingActivitiesInd
Donor Advised Fund	false	DonorAdvisedFundInd
Conservation Easements	false	ConservationEasementsInd
Collections Of Art	false	CollectionsOfArtInd
Credit Counseling	false	CreditCounselingInd
Donor Rstr Or Quasi Endowments	Yes (true)	DonorRstrOrQuasiEndowmentsInd
Report Land Building Equipment	Yes (true)	ReportLandBuildingEquipmentInd
Report Investments Other Sec	false	ReportInvestmentsOtherSecInd
Report Program Related Invst	false	ReportProgramRelatedInvstInd
Report Other Assets	Yes (true)	ReportOtherAssetsInd
Report Other Liabilities	Yes (true)	ReportOtherLiabilitiesInd
Include FIN48 Footnote	false	IncludeFIN48FootnoteInd
Independent Audit Fincl Stmt	false	IndependentAuditFinclStmtInd
Consolidated Audit Fincl Stmt	Yes (true)	ConsolidatedAuditFinclStmtInd
School Operating	false	SchoolOperatingInd
Foreign Office	false	ForeignOfficeInd
Foreign Activities	Yes (true)	ForeignActivitiesInd
More Than5000 K To Org	false	MoreThan5000KToOrgInd
More Than5000 K To Individuals	false	MoreThan5000KToIndividualsInd
Professional Fundraising	Yes (true)	ProfessionalFundraisingInd
Fundraising Activities	Yes (true)	FundraisingActivitiesInd
Gaming Activities	false	GamingActivitiesInd
Operate Hospital	Yes (true)	OperateHospitalInd
Audited Financial Stmt Att	Yes (true)	AuditedFinancialStmtAttInd
Grants To Organizations	Yes (true)	GrantsToOrganizationsInd
Grants To Individuals	Yes (true)	GrantsToIndividualsInd
Schedule J Required	Yes (true)	ScheduleJRequiredInd
Tax Exempt Bonds	Yes (true)	TaxExemptBondsInd
Invest Tax Exempt Bonds	false	InvestTaxExemptBondsInd
Escrow Account	false	EscrowAccountInd
On Behalf Of Issuer	false	OnBehalfOfIssuerInd
Engaged In Excess Benefit Trans	false	EngagedInExcessBenefitTransInd
PY Excess Benefit Trans	false	PYExcessBenefitTransInd
Loan Outstanding	Yes (true)	LoanOutstandingInd
Grant To Related Person	false	GrantToRelatedPersonInd
Business Rln With Org Mem	false	BusinessRlnWithOrgMemInd
Business Rln With Fam Mem	false	BusinessRlnWithFamMemInd
Business Rln With35 Ctrl Ent	false	BusinessRlnWith35CtrlEntInd
Deductible Non Cash Contri	Yes (true)	DeductibleNonCashContriInd
Deductible Art Contribution	false	DeductibleArtContributionInd
Terminate Operations	false	TerminateOperationsInd
Partial Liquidation	false	PartialLiquidationInd
Disregarded Entity	Yes (true)	DisregardedEntityInd
Related Entity	Yes (true)	RelatedEntityInd
Related Organization Ctrl Ent	Yes (true)	RelatedOrganizationCtrlEntInd
Transaction With Control Ent	Yes (true)	TransactionWithControlEntInd
Trnsfr Exmpt Non Chrtbl Rltd Org	Yes (true)	TrnsfrExmptNonChrtblRltdOrgInd
Activities Conducted Prtshp	false	ActivitiesConductedPrtshpInd
Schedule O Required	Yes (true)	ScheduleORequiredInd
Info In Schedule O Part V	Yes (X)	InfoInScheduleOPartVInd
IRP Document	944	IRPDocumentCnt
IRP Document W2 G	0	IRPDocumentW2GCnt
Backup Wthld Compliance	Yes (true)	BackupWthldComplianceInd
Employee	9211	EmployeeCnt
Employment Tax Returns Filed	Yes (true)	EmploymentTaxReturnsFiledInd
Unrelated Bus Incm Over Limit	Yes (true)	UnrelatedBusIncmOverLimitInd
Form990 T Filed	Yes (true)	Form990TFiledInd
Foreign Financial Account	Yes (true)	ForeignFinancialAccountInd
Foreign Country	CJ	ForeignCountryCd
Prohibited Tax Shelter Trans	false	ProhibitedTaxShelterTransInd
Taxable Party Notification	false	TaxablePartyNotificationInd
Nondeductible Contributions	false	NondeductibleContributionsInd
Quid Pro Quo Contributions	Yes (true)	QuidProQuoContributionsInd
Quid Pro Quo Contri Discl	Yes (true)	QuidProQuoContriDisclInd
Form8282 Property Disposed Of	false	Form8282PropertyDisposedOfInd
Rcv Fnds To Pay Prsnl Bnft Cntrct	false	RcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft Cntrct	false	PayPremiumsPrsnlBnftCntrctInd
Indoor Tanning Services	false	IndoorTanningServicesInd
Subj To Tax Rmnrtn Ex Prcht Pymt	Yes (true)	SubjToTaxRmnrtnExPrchtPymtInd
Subject To Excs Tax Net Invst Inc	false	SubjectToExcsTaxNetInvstIncInd
Info In Schedule O Part VI	Yes (X)	InfoInScheduleOPartVIInd
Governing Body Voting Members	65	GoverningBodyVotingMembersCnt
Independent Voting Member	64	IndependentVotingMemberCnt
Family Or Business Rln	Yes (true)	FamilyOrBusinessRlnInd
Delegation Of Mgmt Duties	false	DelegationOfMgmtDutiesInd
Change To Org Documents	false	ChangeToOrgDocumentsInd
Material Diversion Or Misuse	false	MaterialDiversionOrMisuseInd
Members Or Stockholders	false	MembersOrStockholdersInd
Election Of Board Members	false	ElectionOfBoardMembersInd
Decisions Subject To Approva	false	DecisionsSubjectToApprovaInd
Minutes Of Governing Body	Yes (true)	MinutesOfGoverningBodyInd
Minutes Of Committees	Yes (true)	MinutesOfCommitteesInd
Officer Mailing Address	false	OfficerMailingAddressInd
Local Chapters	false	LocalChaptersInd
Form990 Provided To Gvrn Body	Yes (true)	Form990ProvidedToGvrnBodyInd
Conflict Of Interest Policy	Yes (true)	ConflictOfInterestPolicyInd
Annual Disclosure Covered Prsn	Yes (true)	AnnualDisclosureCoveredPrsnInd
Regular Monitoring Enfrc	Yes (true)	RegularMonitoringEnfrcInd
Whistleblower Policy	Yes (true)	WhistleblowerPolicyInd
Document Retention Policy	Yes (true)	DocumentRetentionPolicyInd
Compensation Process CEO	Yes (true)	CompensationProcessCEOInd
Compensation Process Other	Yes (true)	CompensationProcessOtherInd
Investment In Joint Venture	false	InvestmentInJointVentureInd
States Where Copy Of Return Is Fld	CA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	FL	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	GA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	AL	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	IL	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	KS	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	KY	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	LA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	MD	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	MA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	MI	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	MN	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	MS	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	NH	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	NJ	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	NM	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	NC	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	ND	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	OR	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	SC	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	TN	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	UT	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	WI	StatesWhereCopyOfReturnIsFldCd
Upon Request	Yes (X)	UponRequestInd

Books In Care Of Detail BooksInCareOfDetail

Business Name BusinessName

Field	Value	IRS element (for citing)
Business Name Line1	MELISSA CHAMMAS	BusinessNameLine1Txt

Field	Value	IRS element (for citing)
Phone	6176323000	PhoneNum

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	450 BROOKLINE AVE BP418	AddressLine1Txt
City	BOSTON	CityNm
State Abbreviation	MA	StateAbbreviationCd
ZIP	02115	ZIPCd

Form990 Part VII Section A Form990PartVIISectionAGrp (89 entries)

TitleTitleTxt	Average Hours Per WeekAverageHoursPerWeekRt	Average Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRt	Individual Trustee Or DirectorIndividualTrusteeOrDirectorInd	OfficerOfficerInd	Reportable Comp From OrgReportableCompFromOrgAmt	Reportable Comp From Rltd OrgReportableCompFromRltdOrgAmt	Other CompensationOtherCompensationAmt	Key EmployeeKeyEmployeeInd	Highest Compensated EmployeeHighestCompensatedEmployeeInd	Former Ofcr Director TrusteeFormerOfcrDirectorTrusteeInd
JOHN J O'CONNOR
Trustee & Treasurer (END 1/29/24)	2.0	3.0	Yes (X)	Yes (X)	$0	$0	$0
JOSHUA BEKENSTEIN
Trustee & Chairman	2.0	3.0	Yes (X)	Yes (X)	$0	$0	$0
Laurie H Glimcher MD
Trustee, President & CEO	44.0	6.0	Yes (X)	Yes (X)	$2,105,144	$0	$354,681
Lori Whelan
Trustee, Treasurer (AS OF 1/29/24)	2.0	3.0	Yes (X)	Yes (X)	$0	$0	$0
Monica Chandra
Trustee & Secretary	1.0	1.0	Yes (X)	Yes (X)	$0	$0	$0
Richard Lubin
Trustee & Vice-Chairman	2.0	0	Yes (X)	Yes (X)	$0	$0	$0
Afsaneh Beschloss
Trustee	1.0	0	Yes (X)		$0	$0	$0
Alison Jaffe
Trustee	1.0	0	Yes (X)		$0	$0	$0
Amy Berylson
Trustee	1.0	0	Yes (X)		$0	$0	$0
Amy Kyle ESQ
Trustee	1.0	0	Yes (X)		$0	$0	$0
Andrew Janower
Trustee	1.0	0	Yes (X)		$0	$0	$0
Andrew Kaplan
Trustee	1.0	0	Yes (X)		$0	$0	$0
Beth Terrana
Trustee	1.0	0	Yes (X)		$0	$0	$0
Betty Ann Blum
Trustee	1.0	0	Yes (X)		$0	$0	$0
Bradley Lucas
Trustee	1.0	0	Yes (X)		$0	$0	$0
Brian Knez
Trustee	1.0	0	Yes (X)		$0	$0	$0
Christopher J Hadley
Trustee	1.0	1.0	Yes (X)		$0	$0	$0
Demond Martin
Trustee	1.0	0	Yes (X)		$0	$0	$0
Doug Grip
Trustee	1.0	0	Yes (X)		$0	$0	$0
Elizabeth Clymer
Trustee	1.0	0	Yes (X)		$0	$0	$0
Eric Miller
Trustee	1.0	0	Yes (X)		$0	$0	$0
Eric Schlager
Trustee (END 1/29/24)	1.0	0	Yes (X)		$0	$0	$0
Esta Stecher
Trustee	1.0	0	Yes (X)		$0	$0	$0
Fatima Penrose
Trustee	1.0	0	Yes (X)		$0	$0	$0
Frank Laukien
Trustee	1.0	0	Yes (X)		$0	$0	$0
Frederica Williams
Trustee	1.0	0	Yes (X)		$0	$0	$0
Gary Prado
Trustee	1.0	0	Yes (X)		$0	$0	$0
Harvey Berger MD
Trustee	1.0	0	Yes (X)		$0	$0	$0
Hise Gibson
Trustee	1.0	0	Yes (X)		$0	$0	$0
James McCann
Trustee	1.0	0	Yes (X)		$0	$0	$0
Jane Brock-Wilson
Trustee	1.0	0	Yes (X)		$0	$0	$0
Jane Jamieson
Trustee	1.0	0	Yes (X)		$0	$0	$0
Jennifer Perini
Trustee	1.0	0	Yes (X)		$0	$0	$0
Jessica Knez Dulac
Trustee	1.0	0	Yes (X)		$0	$0	$0
Jill Greenthal
Trustee	1.0	0	Yes (X)		$0	$0	$0
Jodi Walker
Trustee	1.0	0	Yes (X)		$0	$0	$0
Jose Aguerrevere
Trustee	1.0	0	Yes (X)		$0	$0	$0
Karen Daley PHD MPH RN FANN
Trustee	1.0	0	Yes (X)		$0	$0	$0
Karen Hale
Trustee (END 4/5/24)	1.0	0	Yes (X)		$0	$0	$0
Karen Linde Packman
Trustee	1.0	0	Yes (X)		$0	$0	$0
Kate Gulliver
Trustee	1.0	0	Yes (X)		$0	$0	$0
Kevin DaSilva
Trustee	1.0	0	Yes (X)		$0	$0	$0
Kimberly Sherman Stamler
Trustee	1.0	0	Yes (X)		$0	$0	$0
Laura Sen
Trustee	1.0	0	Yes (X)		$0	$0	$0
Levi Garraway
Trustee	1.0	0	Yes (X)		$0	$0	$0
Lisa Ferraro
Trustee	1.0	0	Yes (X)		$0	$0	$0
Louise Svanberg
Trustee	1.0	0	Yes (X)		$0	$0	$0
Mary Ann Tocio
Trustee (END 1/29/24)	1.0	0	Yes (X)		$0	$0	$0
Meg Reynolds
Trustee	1.0	0	Yes (X)		$0	$0	$0
Michael Eisenson
Trustee	1.0	0	Yes (X)		$0	$0	$0
Michael Trotsky
Trustee	1.0	0	Yes (X)		$0	$0	$0
Moria Forbes
Trustee	1.0	0	Yes (X)		$0	$0	$0
Nancy Gibson
Trustee	1.0	0	Yes (X)		$0	$0	$0
Nancy Lotane
Trustee	1.0	0	Yes (X)		$0	$0	$0
Paul Marcus
Trustee	1.0	0	Yes (X)		$0	$0	$0
Peter Palandjian
Trustee	1.0	0	Yes (X)		$0	$0	$0
Phillip Gross
Trustee	1.0	0	Yes (X)		$0	$0	$0
Robert Reynolds
Trustee	1.0	0	Yes (X)		$0	$0	$0
Robert Sachs
Trustee (END 1/29/24)	1.0	0	Yes (X)		$0	$0	$0
Robert Stansky
Trustee	1.0	0	Yes (X)		$0	$0	$0
Ronald Sullivan
Trustee	1.0	0	Yes (X)		$0	$0	$0
Sandra Stratford MD
Trustee	1.0	0	Yes (X)		$0	$0	$0
Stephen Fine
Trustee (END 1/29/24)	1.0	0	Yes (X)		$0	$0	$0
Stephen Koster ESQ
Trustee	1.0	0	Yes (X)		$0	$0	$0
Steven Koppel
Trustee	1.0	0	Yes (X)		$0	$0	$0
Susan Alexander ESQ
Trustee	1.0	0	Yes (X)		$0	$0	$0
Susan Poduska
Trustee	1.0	0	Yes (X)		$0	$0	$0
Sushil Tuli
Trustee	1.0	0	Yes (X)		$0	$0	$0
Theodore Pasquarello
Trustee	1.0	0	Yes (X)		$0	$0	$0
Timothy Cohen
Trustee	1.0	0	Yes (X)		$0	$0	$0
Tracey McCain ESQ
Trustee	1.0	0	Yes (X)		$0	$0	$0
Jennifer Willcox ESQ
Asst Secretary & General Counsel	50.0	0		Yes (X)	$692,134	$0	$83,219
Michael L Reney
CFO & Assistant Treasurer	46.0	4.0		Yes (X)	$1,098,939	$0	$50,077
William Hahn MD PHD
COO & EVP	49.0	1.0		Yes (X)	$1,299,728	$0	$50,000
Barrett J Rollins MD PHD
Sr. Advisor to President & CEO	50.0	0			$546,650	$0	$57,960	Yes (X)
Benjamin Ebert MD PhD
CHAIR OF MEDICAL ONCOLOGY	49.0	1.0			$209,100	$0	$15,127	Yes (X)
Craig A Bunnell MD MPH MBA
Chief Medical Officer	50.0	0			$963,956	$0	$53,398	Yes (X)
Jeffrey Meyerhardt MD MPH
Chief Clinical Research Officer	50.0	0			$720,117	$0	$89,568	Yes (X)
Kevin Haigis PHD
Chief Scientific Officer	50.0	0			$667,828	$0	$50,797	Yes (X)
Maria Megdal
SVP Chief Administrative Officer	50.0	0			$670,345	$0	$68,528	Yes (X)
Melany Duval
SVP & Chief Philanthropy Officer	50.0	0			$938,328	$0	$68,330	Yes (X)
Sylvia A Bartel RPh MHP
SR. VP of Pharmacy & CPO	50.0	0			$360,265	$0	$86,038	Yes (X)
Wendy Gettleman
VP of Facilities Management & Real Estate	50.0	0			$389,597	$0	$89,618	Yes (X)
Bruce Johnson MD
Sr. Advisor to President & CEO	49.0	1.0			$749,341	$0	$73,538		Yes (X)
Elizabeth Liebow
Former Key Employee	0.0	0			$1,205,871	$0	$51,580		Yes (X)
Michael Constantine MD
Milford Med Dir-Hematology/Oncology	50.0	0			$800,852	$0	$89,666		Yes (X)
Robert Soiffer MD
Chair Executive Committee for Clinical Programs	50.0	0			$839,239	$0	$69,055		Yes (X)
Scott Armstrong MD PHD
Chair of Pediatric Oncology	50.0	0			$819,691	$0	$81,122		Yes (X)
John O Chesley ESQ
Counsel	0.0	0			$456,000	$0	$0			Yes (X)

Field	Value	IRS element (for citing)
Total Reportable Comp From Org	$15,533,125	TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org	$0	TotReportableCompRltdOrgAmt
Total Other Compensation	$1,482,302	TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K	2568	IndivRcvdGreaterThan100KCnt
Former Ofcr Employees Listed	Yes (true)	FormerOfcrEmployeesListedInd
Total Comp Greater Than150 K	Yes (true)	TotalCompGreaterThan150KInd
Compensation From Other Srcs	false	CompensationFromOtherSrcsInd

Contractor Compensation ContractorCompensationGrp (5 entries)

Address Line1ContractorAddress/USAddress/AddressLine1Txt	CityContractorAddress/USAddress/CityNm	State AbbreviationContractorAddress/USAddress/StateAbbreviationCd	ZIPContractorAddress/USAddress/ZIPCd	ServicesServicesDesc	CompensationCompensationAmt
BRIGHAM AND WOMEN'S HOSPITAL
399 Revolution Drive Ste 645	SOMERVILLE	MA	02145	MEDICAL SERVICES	$218,465,038
CARDINAL HEALTH
7611 Brandon Woods Blvd	Baltimore	MD	21226	MEDICAL SERVICES	$51,419,215
South Shore Hospital
55 Fogg Rd South	Weymouth	MA	02190	Medical Services	$30,341,819
Advanced Accelerator Applications USA Inc
350 Fifth Avenue	New York	NY	10118	Radiotherapy	$30,133,420
Cardinal Health 110 Inc
11 Centennial Dr	Peabody	MA	019616041	Medical Services	$26,322,891

Field	Value	IRS element (for citing)
Cntrct Rcvd Greater Than100 K	640	CntrctRcvdGreaterThan100KCnt
Federated Campaigns	$96,814	FederatedCampaignsAmt
Fundraising	$23,200,209	FundraisingAmt
Related Organizations	$887,893	RelatedOrganizationsAmt
Government Grants	$190,820,918	GovernmentGrantsAmt
All Other Contributions	$564,147,867	AllOtherContributionsAmt
Noncash Contributions	$33,140,511	NoncashContributionsAmt
Total Contributions	$779,153,701	TotalContributionsAmt

Program Service Revenue ProgramServiceRevenueGrp (3 entries)

DescDesc	BusinessBusinessCd	Total Revenue ColumnTotalRevenueColumnAmt	Related Or Exempt Func IncomeRelatedOrExemptFuncIncomeAmt
NET PATIENT SERVICE REVENUE	621110	$2,599,181,707	$2,599,181,707
NETWORK COLLABORATION	900099	$9,721,644	$9,721,644
LINAC	621500	$2,587,713	$2,587,713

Total Oth Program Service Rev TotalOthProgramServiceRevGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$0	TotalRevenueColumnAmt
Related Or Exempt Func Income	$0	RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue	$0	UnrelatedBusinessRevenueAmt
Exclusion	$0	ExclusionAmt

Field	Value	IRS element (for citing)
Total Program Service Revenue	$2,611,491,064	TotalProgramServiceRevenueAmt

Investment Income InvestmentIncomeGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$5,694,108	TotalRevenueColumnAmt
Exclusion	$5,694,108	ExclusionAmt

Royalties Revenue RoyaltiesRevenueGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$63,118,132	TotalRevenueColumnAmt
Exclusion	$63,118,132	ExclusionAmt

Gross Rents GrossRentsGrp

Field	Value	IRS element (for citing)
Real	$1,396,784	RealAmt

Rental Income Or Loss RentalIncomeOrLossGrp

Field	Value	IRS element (for citing)
Real	$1,396,784	RealAmt
Personal	$0	PersonalAmt

Net Rental Income Or Loss NetRentalIncomeOrLossGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$1,396,784	TotalRevenueColumnAmt
Exclusion	$1,396,784	ExclusionAmt

Gain Or Loss GainOrLossGrp

Field	Value	IRS element (for citing)
Securities	$0	SecuritiesAmt
Other	$0	OtherAmt

Field	Value	IRS element (for citing)
Fundraising Gross Income	$480,682	FundraisingGrossIncomeAmt
Contri Rpt Fundraising Event	$23,200,209	ContriRptFundraisingEventAmt
Fundraising Direct Expenses	$3,808,166	FundraisingDirectExpensesAmt

Net Incm From Fundraising Evt NetIncmFromFundraisingEvtGrp

Field	Value	IRS element (for citing)
Total Revenue Column	-$3,327,484	TotalRevenueColumnAmt
Exclusion	-$3,327,484	ExclusionAmt

Other Revenue Misc OtherRevenueMiscGrp (3 entries)

DescDesc	BusinessBusinessCd	Total Revenue ColumnTotalRevenueColumnAmt	ExclusionExclusionAmt
FOOD SERVICE REVENUE	722514	$5,102,880	$5,102,880
PARKING LOT REVENUE	812930	$4,997,539	$4,997,539
BOUTIQUE/GIFT SHOP	456199	$1,005,014	$1,005,014

Miscellaneous Revenue MiscellaneousRevenueGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$2,962,972	TotalRevenueColumnAmt
Related Or Exempt Func Income	$0	RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue	$41,707	UnrelatedBusinessRevenueAmt
Exclusion	$2,921,265	ExclusionAmt

Field	Value	IRS element (for citing)
Other Revenue Total	$14,068,405	OtherRevenueTotalAmt

Total Revenue TotalRevenueGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$3,471,594,710	TotalRevenueColumnAmt
Related Or Exempt Func Income	$2,611,491,064	RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue	$41,707	UnrelatedBusinessRevenueAmt
Exclusion	$80,908,238	ExclusionAmt

Grants To Domestic Orgs GrantsToDomesticOrgsGrp

Field	Value	IRS element (for citing)
Total	$4,314,031	TotalAmt
Program Services	$4,314,031	ProgramServicesAmt

Grants To Domestic Individuals GrantsToDomesticIndividualsGrp

Field	Value	IRS element (for citing)
Total	$3,266,966	TotalAmt
Program Services	$3,266,966	ProgramServicesAmt

Benefits To Members BenefitsToMembersGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt
Program Services	$0	ProgramServicesAmt

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

Field	Value	IRS element (for citing)
Total	$10,662,131	TotalAmt
Program Services	$3,467,916	ProgramServicesAmt
Management And General	$6,255,887	ManagementAndGeneralAmt
Fundraising	$938,328	FundraisingAmt

Comp Disqual Persons CompDisqualPersonsGrp

Field	Value	IRS element (for citing)
Total	$2,411,212	TotalAmt
Program Services	$1,955,212	ProgramServicesAmt
Management And General	$456,000	ManagementAndGeneralAmt
Fundraising	$0	FundraisingAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

Field	Value	IRS element (for citing)
Total	$849,847,817	TotalAmt
Program Services	$722,094,797	ProgramServicesAmt
Management And General	$96,484,783	ManagementAndGeneralAmt
Fundraising	$31,268,237	FundraisingAmt

Pension Plan Contributions PensionPlanContributionsGrp

Field	Value	IRS element (for citing)
Total	$54,571,334	TotalAmt
Program Services	$46,008,402	ProgramServicesAmt
Management And General	$6,526,181	ManagementAndGeneralAmt
Fundraising	$2,036,751	FundraisingAmt

Other Employee Benefits OtherEmployeeBenefitsGrp

Field	Value	IRS element (for citing)
Total	$104,905,987	TotalAmt
Program Services	$88,444,912	ProgramServicesAmt
Management And General	$12,641,789	ManagementAndGeneralAmt
Fundraising	$3,819,286	FundraisingAmt

Payroll Taxes PayrollTaxesGrp

Field	Value	IRS element (for citing)
Total	$60,077,503	TotalAmt
Program Services	$50,650,583	ProgramServicesAmt
Management And General	$7,184,664	ManagementAndGeneralAmt
Fundraising	$2,242,256	FundraisingAmt

Fees For Services Management FeesForServicesManagementGrp

Field	Value	IRS element (for citing)
Total	$5,597,203	TotalAmt
Program Services	$4,927,775	ProgramServicesAmt
Management And General	$669,214	ManagementAndGeneralAmt
Fundraising	$214	FundraisingAmt

Fees For Services Legal FeesForServicesLegalGrp

Field	Value	IRS element (for citing)
Total	$19,812,072	TotalAmt
Program Services	$11,423,703	ProgramServicesAmt
Management And General	$8,388,369	ManagementAndGeneralAmt
Fundraising	$0	FundraisingAmt

Fees For Services Accounting FeesForServicesAccountingGrp

Field	Value	IRS element (for citing)
Total	$979,575	TotalAmt
Program Services	$0	ProgramServicesAmt
Management And General	$979,575	ManagementAndGeneralAmt
Fundraising	$0	FundraisingAmt

Fees For Services Lobbying FeesForServicesLobbyingGrp

Field	Value	IRS element (for citing)
Total	$764,891	TotalAmt
Program Services	$764,891	ProgramServicesAmt
Management And General	$0	ManagementAndGeneralAmt
Fundraising	$0	FundraisingAmt

Fees For Services Prof Fundraising FeesForServicesProfFundraising

Field	Value	IRS element (for citing)
Total	$5,632,350	TotalAmt
Fundraising	$5,632,350	FundraisingAmt

Fees For Services Other FeesForServicesOtherGrp

Field	Value	IRS element (for citing)
Total	$109,902,186	TotalAmt
Program Services	$87,633,393	ProgramServicesAmt
Management And General	$21,520,288	ManagementAndGeneralAmt
Fundraising	$748,505	FundraisingAmt

Advertising AdvertisingGrp

Field	Value	IRS element (for citing)
Total	$10,190,777	TotalAmt
Program Services	$7,031,784	ProgramServicesAmt
Management And General	$2,033,117	ManagementAndGeneralAmt
Fundraising	$1,125,876	FundraisingAmt

Office Expenses OfficeExpensesGrp

Field	Value	IRS element (for citing)
Total	$26,630,397	TotalAmt
Program Services	$21,401,140	ProgramServicesAmt
Management And General	$4,255,319	ManagementAndGeneralAmt
Fundraising	$973,938	FundraisingAmt

Information Technology InformationTechnologyGrp

Field	Value	IRS element (for citing)
Total	$95,779,401	TotalAmt
Program Services	$87,697,631	ProgramServicesAmt
Management And General	$7,931,608	ManagementAndGeneralAmt
Fundraising	$150,162	FundraisingAmt

Occupancy OccupancyGrp

Field	Value	IRS element (for citing)
Total	$159,959,259	TotalAmt
Program Services	$134,829,329	ProgramServicesAmt
Management And General	$25,126,261	ManagementAndGeneralAmt
Fundraising	$3,669	FundraisingAmt

Travel TravelGrp

Field	Value	IRS element (for citing)
Total	$12,069,110	TotalAmt
Program Services	$10,838,039	ProgramServicesAmt
Management And General	$1,119,421	ManagementAndGeneralAmt
Fundraising	$111,650	FundraisingAmt

Conferences Meetings ConferencesMeetingsGrp

Field	Value	IRS element (for citing)
Total	$4,702,975	TotalAmt
Program Services	$1,169,717	ProgramServicesAmt
Management And General	$2,491,939	ManagementAndGeneralAmt
Fundraising	$1,041,319	FundraisingAmt

Interest InterestGrp

Field	Value	IRS element (for citing)
Total	$26,930,048	TotalAmt
Program Services	$26,633,712	ProgramServicesAmt
Management And General	$296,336	ManagementAndGeneralAmt
Fundraising	$0	FundraisingAmt

Depreciation Depletion DepreciationDepletionGrp

Field	Value	IRS element (for citing)
Total	$89,512,612	TotalAmt
Program Services	$79,314,907	ProgramServicesAmt
Management And General	$10,197,705	ManagementAndGeneralAmt
Fundraising	$0	FundraisingAmt

Insurance InsuranceGrp

Field	Value	IRS element (for citing)
Total	$8,660,747	TotalAmt
Program Services	$284,665	ProgramServicesAmt
Management And General	$8,376,082	ManagementAndGeneralAmt
Fundraising	$0	FundraisingAmt

Other Expenses OtherExpensesGrp (4 entries)

DescDesc	TotalTotalAmt	Program ServicesProgramServicesAmt	Management And GeneralManagementAndGeneralAmt	FundraisingFundraisingAmt
PHARMACEUTICALS	$1,336,948,205	$1,336,948,205	$0	$0
MEDICAL SUPPLIES	$141,916,291	$141,516,183	$400,108	$0
OTHER PATIENT CARE EXPENSE	$47,110,602	$47,110,602	$0	$0
BAD DEBT EXPENSE	$5,200,375	$5,200,375	$0	$0

All Other Expenses AllOtherExpensesGrp

Field	Value	IRS element (for citing)
Total	$159,788,700	TotalAmt
Program Services	$151,493,104	ProgramServicesAmt
Management And General	$7,682,238	ManagementAndGeneralAmt
Fundraising	$613,358	FundraisingAmt

Total Functional Expenses TotalFunctionalExpensesGrp

Field	Value	IRS element (for citing)
Total	$3,358,144,757	TotalAmt
Program Services	$3,076,421,974	ProgramServicesAmt
Management And General	$231,016,884	ManagementAndGeneralAmt
Fundraising	$50,705,899	FundraisingAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

Field	Value	IRS element (for citing)
BOY	$89,329,951	BOYAmt
EOY	$81,120,933	EOYAmt

Pledges And Grants Receivable PledgesAndGrantsReceivableGrp

Field	Value	IRS element (for citing)
BOY	$86,742,438	BOYAmt
EOY	$81,609,743	EOYAmt

Accounts Receivable AccountsReceivableGrp

Field	Value	IRS element (for citing)
BOY	$302,351,892	BOYAmt
EOY	$338,818,104	EOYAmt

Receivables From Officers Etc ReceivablesFromOfficersEtcGrp

Field	Value	IRS element (for citing)
BOY	$479,137	BOYAmt
EOY	$488,479	EOYAmt

Rcvbl From Disqualified Prsn RcvblFromDisqualifiedPrsnGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Inventories For Sale Or Use InventoriesForSaleOrUseGrp

Field	Value	IRS element (for citing)
BOY	$82,174,522	BOYAmt
EOY	$87,864,118	EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

Field	Value	IRS element (for citing)
BOY	$106,554,859	BOYAmt
EOY	$137,272,053	EOYAmt

Field	Value	IRS element (for citing)
Land Bldg Equip Cost Or Other Bss	$2,281,047,728	LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec	$1,295,184,618	LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

Field	Value	IRS element (for citing)
BOY	$933,280,803	BOYAmt
EOY	$985,863,110	EOYAmt

Investments Other Securities InvestmentsOtherSecuritiesGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt

Investments Program Related InvestmentsProgramRelatedGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt

Intangible Assets IntangibleAssetsGrp

Field	Value	IRS element (for citing)
BOY	$7,894,580	BOYAmt
EOY	$7,894,580	EOYAmt

Other Assets Total OtherAssetsTotalGrp

Field	Value	IRS element (for citing)
BOY	$3,126,436,883	BOYAmt
EOY	$3,627,945,507	EOYAmt

Total Assets TotalAssetsGrp

Field	Value	IRS element (for citing)
BOY	$4,735,245,065	BOYAmt
EOY	$5,348,876,627	EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

Field	Value	IRS element (for citing)
BOY	$212,881,914	BOYAmt
EOY	$253,302,762	EOYAmt

Tax Exempt Bond Liabilities TaxExemptBondLiabilitiesGrp

Field	Value	IRS element (for citing)
BOY	$487,342,000	BOYAmt
EOY	$479,709,000	EOYAmt

Loans From Officers Directors LoansFromOfficersDirectorsGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Mortg Notes Pybl Scrd Invst Prop MortgNotesPyblScrdInvstPropGrp

Field	Value	IRS element (for citing)
BOY	$69,357,000	BOYAmt
EOY	$67,364,000	EOYAmt

Other Liabilities OtherLiabilitiesGrp

Field	Value	IRS element (for citing)
BOY	$605,089,312	BOYAmt
EOY	$637,419,474	EOYAmt

Total Liabilities TotalLiabilitiesGrp

Field	Value	IRS element (for citing)
BOY	$1,374,670,226	BOYAmt
EOY	$1,437,795,236	EOYAmt

Field	Value	IRS element (for citing)
Organization Follows FASB117	Yes (X)	OrganizationFollowsFASB117Ind

No Donor Restriction Net Assets NoDonorRestrictionNetAssetsGrp

Field	Value	IRS element (for citing)
BOY	$1,735,209,356	BOYAmt
EOY	$2,005,198,802	EOYAmt

Donor Restriction Net Assets DonorRestrictionNetAssetsGrp

Field	Value	IRS element (for citing)
BOY	$1,625,365,483	BOYAmt
EOY	$1,905,882,589	EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

Field	Value	IRS element (for citing)
BOY	$3,360,574,839	BOYAmt
EOY	$3,911,081,391	EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

Field	Value	IRS element (for citing)
BOY	$4,735,245,065	BOYAmt
EOY	$5,348,876,627	EOYAmt

Field	Value	IRS element (for citing)
Info In Schedule O Part XI	Yes (X)	InfoInScheduleOPartXIInd
Reconcilation Revenue Expnss	$113,449,953	ReconcilationRevenueExpnssAmt
Other Changes In Net Assets	$437,056,599	OtherChangesInNetAssetsAmt
Method Of Accounting Accrual	Yes (X)	MethodOfAccountingAccrualInd
Accountant Compile Or Review	false	AccountantCompileOrReviewInd
FS Audited	Yes (true)	FSAuditedInd

FS Audited Basis FSAuditedBasisGrp

Field	Value	IRS element (for citing)
Consolidated Basis Fincl Stmt	Yes (X)	ConsolidatedBasisFinclStmtInd

Field	Value	IRS element (for citing)
Audit Committee	Yes (true)	AuditCommitteeInd
Federal Grant Audit Required	Yes (true)	FederalGrantAuditRequiredInd
Federal Grant Audit Performed	Yes (true)	FederalGrantAuditPerformedInd

Schedule A IRS990ScheduleA

Field	Value	IRS element (for citing)
Public Organization170	Yes (X)	PublicOrganization170Ind

Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$629,412,126	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$726,297,460	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$702,430,542	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$761,032,475	CurrentTaxYearMinus1YearAmt
Current Tax Year	$779,153,701	CurrentTaxYearAmt
Total	$3,598,326,304	TotalAmt

Tax Rev Levied Orgnztnl Bnft170 TaxRevLeviedOrgnztnlBnft170Grp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Govt Furn Srvc Fclts Vl170 GovtFurnSrvcFcltsVl170Grp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Total Calendar Year170 TotalCalendarYear170Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$629,412,126	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$726,297,460	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$702,430,542	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$761,032,475	CurrentTaxYearMinus1YearAmt
Current Tax Year	$779,153,701	CurrentTaxYearAmt
Total	$3,598,326,304	TotalAmt

Field	Value	IRS element (for citing)
Substantial Contributors Tot	$0	SubstantialContributorsTotAmt
Public Support Total170	$3,598,326,304	PublicSupportTotal170Amt

Gross Investment Income170 GrossInvestmentIncome170Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$52,614,894	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$113,415,703	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$44,851,524	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$334,501,187	CurrentTaxYearMinus1YearAmt
Current Tax Year	$70,209,024	CurrentTaxYearAmt
Total	$615,592,332	TotalAmt

Unrelated Business Net Incm170 UnrelatedBusinessNetIncm170Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$126,581	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$93,395	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$65,661	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$0	CurrentTaxYearMinus1YearAmt
Current Tax Year	$41,707	CurrentTaxYearAmt
Total	$327,344	TotalAmt

Other Income170 OtherIncome170Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$14,915,439	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$7,706,225	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$13,596,972	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$16,868,465	CurrentTaxYearMinus1YearAmt
Current Tax Year	$14,507,380	CurrentTaxYearAmt
Total	$67,594,481	TotalAmt

Field	Value	IRS element (for citing)
Total Support	$4,281,840,461	TotalSupportAmt
Gross Receipts Rltd Activities	$9,684,367,686	GrossReceiptsRltdActivitiesAmt
Public Support CY170	0.8404	PublicSupportCY170Pct
Public Support PY170	0.8274	PublicSupportPY170Pct
Thirty Thr Pct Suprt Tests CY170	Yes (X)	ThirtyThrPctSuprtTestsCY170Ind

Form990 Schedule A Part VI Form990ScheduleAPartVIGrp

Field	Value	IRS element (for citing)
Form And Line Reference	Schedule A, Part II, Line 10 Other Income	FormAndLineReferenceDesc
Explanation	DESCRIPTION - PARKING LOT REVENUE, COLUMN A - 3877282.0, COLUMN B - 3167144.0, COLUMN C - 4721708.0, COLUMN D - 4855402.0, COLUMN E - 4997539.0, COLUMN F - 21619075.0; DESCRIPTION - FOOD SERVICE REVENUE, COLUMN A - 2743883.0, COLUMN B - 2516332.0, COLUMN C - 3633966.0, COLUMN D - 4388191.0, COLUMN E - 5102880.0, COLUMN F - 18385252.0; DESCRIPTION - SURPLUS CAPITAL DISTRIBUTION, COLUMN A - 0.0, COLUMN B - 0.0, COLUMN C - 1820768.0, COLUMN D - 0.0, COLUMN E - 0.0, COLUMN F - 1820768.0; DESCRIPTION - MISCELLANOUS REVENUE, COLUMN A - 7376177.0, COLUMN B - 1067783.0, COLUMN C - 2815275.0, COLUMN D - 3125300.0, COLUMN E - 2921265.0, COLUMN F - 17305800.0; DESCRIPTION - FUNDRAISING EVENTS, COLUMN A - 270462.0, COLUMN B - 256368.0, COLUMN C - 605255.0, COLUMN D - 499572.0, COLUMN E - 480682.0, COLUMN F - 2112339.0; DESCRIPTION - DISTRIBUTION FROM DFMGBCC, COLUMN A - 0.0, COLUMN B - 0.0, COLUMN C - 0.0, COLUMN D - 4000000.0, COLUMN E - 0.0, COLUMN F - 4000000.0; DESCRIPTION - BOUTIQUE, COLUMN A - 647635.0, COLUMN B - 698598.0, COLUMN C - 0.0, COLUMN D - 0.0, COLUMN E - 1005014.0, COLUMN F - 2351247.0;	ExplanationTxt

Schedule B IRS990ScheduleB

Contributor Information ContributorInformationGrp

Field	Value	IRS element (for citing)
Contributor	RESTRICTED	ContributorNum

Contributor Business Name ContributorBusinessName

Field	Value	IRS element (for citing)
Business Name Line1	RESTRICTED	BusinessNameLine1

Contributor US Address ContributorUSAddress

Field	Value	IRS element (for citing)
Address Line1	RESTRICTED	AddressLine1
Address Line2	RESTRICTED	AddressLine2
City	RESTRICTED	City
State	RESTRICTED	State
ZIP Code	RESTRICTED	ZIPCode

Field	Value	IRS element (for citing)
Total Contributions	RESTRICTED	TotalContributionsAmt

Schedule C IRS990ScheduleC

Field	Value	IRS element (for citing)
Volunteers	Yes (true)	VolunteersInd
Paid Staff Or Management	Yes (true)	PaidStaffOrManagementInd
Media Advertisements	false	MediaAdvertisementsInd
Mailings Members	false	MailingsMembersInd
Publications Or Broadcast	false	PublicationsOrBroadcastInd
Grants Other Organizations	Yes (true)	GrantsOtherOrganizationsInd
Grants Other Organizations	$474,897	GrantsOtherOrganizationsAmt
Direct Contact Legislators	Yes (true)	DirectContactLegislatorsInd
Direct Contact Legislators	$289,994	DirectContactLegislatorsAmt
Rallies Demonstrations	false	RalliesDemonstrationsInd
Other Activities	false	OtherActivitiesInd
Total Lobbying Expenditures	$764,891	TotalLobbyingExpendituresAmt
Not Described Section501c3	false	NotDescribedSection501c3Ind

Supplemental Information Detail SupplementalInformationDetail

Field	Value	IRS element (for citing)
Form And Line Reference	Schedule C, Part II-B	FormAndLineReferenceDesc
Explanation	VAN SCOYOC & ASSOCIATES PROVIDED FEDERAL LEGISLATIVE CONSULTING FOR DANA-FARBER CANCER INSTITUTE, INC. (DFCI). ALSTON & BIRD LLP PROVIDED FEDERAL LEGISLATIVE CONSULTING FOR DFCI. MCDERMOTT, QUILTY & MILLER, LLP PROVIDED STATE LEGISLATIVE AND GOVERNMENT RELATIONS CONSULTING FOR DFCI. CONFERENCE OF BOSTON TEACHING HOSPITALS PROVIDED STATE AND FEDERAL LOBBYING SUPPORT TO DFCI. ALLIANCE OF DEDICATED CANCER CENTERS REPRESENTS THE NATION'S TEN FREESTANDING CANCER CENTERS. WE WORK TOGETHER ON FEDERAL REGULATORY, LEGISLATIVE, AND REIMBURSEMENT ISSUES UNIQUE TO DEDICATED CANCER CENTERS. CQ ROLL CALL PROVIDES GRASSROOTS ADVOCACY SOFTWARE USED FOR EMAILS AND ACTION ALERTS ON ADVOCACY ISSUES WHICH ARE SENT TO MEMBERS OF DANA-FARBER'S LEGISLATIVE ACTION NETWORK (LAN). DFCI'S LAN ADVOCATES FOR LEGISLATION AND POLICIES THAT IMPROVE THE LIVES OF CANCER PATIENTS. DFCI IS A MEMBER OF THE AMERICAN HOSPITAL ASSOCIATION AND THE MASSACHUSETTS HOSPITAL ASSOCIATION, NOT-FOR-PROFIT ORGANIZATIONS THAT REPRESENT AND ADVOCATE FOR THE COLLECTIVE INTERESTS OF THEIR MEMBER HOSPITALS AND HEALTH SYSTEMS THROUGH LEADERSHIP IN PUBLIC ADVOCACY, EDUCATION, AND INFORMATION. A PORTION OF THE MEMBERSHIP DUES TO THESE ORGANIZATIONS ARE USED FOR LOBBYING ACTIVITIES. ON OCCASION, DFCI EXECUTIVE LEADERSHIP MEET WITH STATE AND FEDERAL ELECTED OFFICIALS TO ADVOCATE FOR THE PASSAGE OF LEGISLATION AND FUNDING TO ADVANCE CANCER RESEARCH AND TREATMENT, AND LEGISLATION TO SUPPORT SERVICES FOR CANCER PATIENTS AND CANCER SURVIVORS. IN ADDITION, DFCI SUBMITS LETTERS AND/OR TESTIMONY TO ELECTED OFFICIALS AND POLICY MAKERS ON THESE ISSUES.	ExplanationTxt

Schedule D IRS990ScheduleD

CY Endwmt Fund CYEndwmtFundGrp

Field	Value	IRS element (for citing)
Beginning Year Balance	$458,787,000	BeginningYearBalanceAmt
Contributions	$21,098,000	ContributionsAmt
Investment Earnings Or Losses	$77,016,000	InvestmentEarningsOrLossesAmt
Other Expenditures	$30,438,000	OtherExpendituresAmt
End Year Balance	$526,463,000	EndYearBalanceAmt

CY Minus1 Yr Endwmt Fund CYMinus1YrEndwmtFundGrp

Field	Value	IRS element (for citing)
Beginning Year Balance	$430,270,000	BeginningYearBalanceAmt
Contributions	$18,963,000	ContributionsAmt
Investment Earnings Or Losses	$38,462,000	InvestmentEarningsOrLossesAmt
Other Expenditures	$28,908,000	OtherExpendituresAmt
End Year Balance	$458,787,000	EndYearBalanceAmt

CY Minus2 Yr Endwmt Fund CYMinus2YrEndwmtFundGrp

Field	Value	IRS element (for citing)
Beginning Year Balance	$479,196,000	BeginningYearBalanceAmt
Contributions	$29,347,000	ContributionsAmt
Investment Earnings Or Losses	-$55,371,000	InvestmentEarningsOrLossesAmt
Other Expenditures	$22,902,000	OtherExpendituresAmt
End Year Balance	$430,270,000	EndYearBalanceAmt

CY Minus3 Yr Endwmt Fund CYMinus3YrEndwmtFundGrp

Field	Value	IRS element (for citing)
Beginning Year Balance	$357,421,000	BeginningYearBalanceAmt
Contributions	$14,528,000	ContributionsAmt
Investment Earnings Or Losses	$122,237,000	InvestmentEarningsOrLossesAmt
Other Expenditures	$14,990,000	OtherExpendituresAmt
End Year Balance	$479,196,000	EndYearBalanceAmt

CY Minus4 Yr Endwmt Fund CYMinus4YrEndwmtFundGrp

Field	Value	IRS element (for citing)
Beginning Year Balance	$313,020,000	BeginningYearBalanceAmt
Contributions	$21,879,000	ContributionsAmt
Investment Earnings Or Losses	$41,043,000	InvestmentEarningsOrLossesAmt
Other Expenditures	$18,521,000	OtherExpendituresAmt
End Year Balance	$357,421,000	EndYearBalanceAmt

Field	Value	IRS element (for citing)
Board Designated Balance EOY	0.0	BoardDesignatedBalanceEOYPct
Prmnnt Endowment Balance EOY	0.6116	PrmnntEndowmentBalanceEOYPct
Term Endowment Balance EOY	0.3884	TermEndowmentBalanceEOYPct
Endowments Held Unrelated Org	false	EndowmentsHeldUnrelatedOrgInd
Endowments Held Related Org	Yes (true)	EndowmentsHeldRelatedOrgInd
Related Org List Sch R	Yes (true)	RelatedOrgListSchRInd

Land LandGrp

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	$17,067,029	OtherCostOrOtherBasisAmt
Book Value	$17,067,029	BookValueAmt

Buildings BuildingsGrp

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	$1,334,529,745	OtherCostOrOtherBasisAmt
Depreciation	$760,017,552	DepreciationAmt
Book Value	$574,512,193	BookValueAmt

Leasehold Improvements LeaseholdImprovementsGrp

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	$371,026,451	OtherCostOrOtherBasisAmt
Depreciation	$180,178,911	DepreciationAmt
Book Value	$190,847,540	BookValueAmt

Equipment EquipmentGrp

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	$425,435,621	OtherCostOrOtherBasisAmt
Depreciation	$354,988,155	DepreciationAmt
Book Value	$70,447,466	BookValueAmt

Other Land Buildings OtherLandBuildingsGrp

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	$132,988,882	OtherCostOrOtherBasisAmt
Book Value	$132,988,882	BookValueAmt

Field	Value	IRS element (for citing)
Total Book Value Land Buildings	$985,863,110	TotalBookValueLandBuildingsAmt

Other Assets Org OtherAssetsOrgGrp (4 entries)

DescDesc	Book ValueBookValueAmt
INTEREST IN DANA-FARBER, INC.	$3,128,274,514
RIGHT OF USE - NET OPERATING LEASES	$342,830,248
RESEARCH RECEIVABLES	$86,588,933
MISCELLANEOUS ASSETS	$70,251,812

Field	Value	IRS element (for citing)
Total Book Value Other Assets	$3,627,945,507	TotalBookValueOtherAssetsAmt

Other Liabilities Org OtherLiabilitiesOrgGrp (6 entries)

DescDesc	AmtAmt
OPERATING LEASE LIABILITIES	$368,294,704
RESEARCH ADVANCES	$155,672,652
AMOUNTS DUE THIRD PARTY PAYOR	$69,901,190
SWAP VALUATION LIABILITY	$22,704,503
MISCELLANEOUS LIABILITIES	$18,614,425
PROVISION FOR MEDICAL MALPRACTICE CLAIMS	$2,232,000

Field	Value	IRS element (for citing)
Total Liability	$637,419,474	TotalLiabilityAmt

Supplemental Information Detail SupplementalInformationDetail

Field	Value	IRS element (for citing)
Form And Line Reference	Schedule D, Part V, Line 4 Intended uses of endowment funds	FormAndLineReferenceDesc
Explanation	DANA-FARBER, INC. (DFI) A RELATED ORGANIZATION OF DANA-FARBER CANCER INSTITUTE, INC. (DFCI) HOLDS THE ENDOWMENTS FOR DFCI. AS DESCRIBED IN THE CONSOLIDATED AUDITED FINANCIAL STATEMENTS, DFCI'S ENDOWMENTS CONSIST SOLELY OF DONOR-RESTRICTED ENDOWMENT FUNDS ESTABLISHED FOR PURPOSES DIRECTLY RELATED TO DFCI'S EXEMPT MISSION AND PURPOSES. AS REQUIRED BY GENERALLY ACCEPTED ACCOUNTING PRINCIPLES, NEW ASSETS ASSOCIATED WITH ENDOWMENT FUNDS ARE CLASSIFIED AND REPORTED BASED ON THE EXISTENCE OR ABSENCE OF DONOR-IMPOSED RESTRICTIONS. ALL USES OF DFCI'S ENDOWMENT FUNDS ARE IN FURTHERANCE OF DFCI'S EXEMPT MISSION AND PURPOSES.	ExplanationTxt

Schedule F IRS990ScheduleF

Account Activities Outside US AccountActivitiesOutsideUSGrp (9 entries)

RegionRegionTxt	Type Of Activities ConductedTypeOfActivitiesConductedTxt	Specific Services ProvidedSpecificServicesProvidedTxt	Region Total ExpendituresRegionTotalExpendituresAmt
Europe (Including Iceland and Greenland)	Program Services	Subcontracted Research	$4,127,000
South Asia	Program Services	Subcontracted Research	$983,000
East Asia and the Pacific	Program Services	Subcontracted Research	$929,000
North America (Canada & Mexico only)	Program Services	Subcontracted Research	$842,000
East Asia and the Pacific	Program Services	RESEARCH AND EDUCATION	$814,000
South America	Program Services	RESEARCH AND EDUCATION	$615,000
Sub-Saharan Africa	Program Services	Subcontracted Research	$229,000
Middle East and North Africa	Program Services	RESEARCH AND EDUCATION	$81,000
Middle East and North Africa	Program Services	Subcontracted Research	$20,000

Field	Value	IRS element (for citing)
Subtotal Offices	0	SubtotalOfficesCnt
Subtotal Employees	0	SubtotalEmployeesCnt
Continuation Total Office	0	ContinuationTotalOfficeCnt
Continuation Total Employee	0	ContinuationTotalEmployeeCnt
Total Office	0	TotalOfficeCnt
Total Employee	0	TotalEmployeeCnt
Subtotal Spent	$8,640,000	SubtotalSpentAmt
Continuation Spent	$0	ContinuationSpentAmt
Total Spent	$8,640,000	TotalSpentAmt
Transfer To Foreign Corp	false	TransferToForeignCorpInd
Interest In Foreign Trust	false	InterestInForeignTrustInd
Foreign Corp Ownership	Yes (true)	ForeignCorpOwnershipInd
Passive Foreign Investmest Co	false	PassiveForeignInvestmestCoInd
Foreign Partnership	false	ForeignPartnershipInd
Boycott Countries	Yes (true)	BoycottCountriesInd

Supplemental Information Detail SupplementalInformationDetail

Field	Value	IRS element (for citing)
Form And Line Reference	Schedule F, Part I, Line 3 Method used to account for expenditures on org's financial statements	FormAndLineReferenceDesc
Explanation	EAST ASIA AND THE PACIFIC-Accrual; EUROPE (INCLUDING ICELAND AND GREENLAND)-Accrual; MIDDLE EAST AND NORTH AFRICA-Accrual; NORTH AMERICA (CANADA & MEXICO ONLY)-Accrual; SOUTH AMERICA-Accrual; SOUTH ASIA-Accrual; SUB-SAHARAN AFRICA-Accrual	ExplanationTxt

Schedule G IRS990ScheduleG

Field	Value	IRS element (for citing)
Mail Solicitations	Yes (X)	MailSolicitationsInd
Email Solicitations	Yes (X)	EmailSolicitationsInd
Phone Solicitations	Yes (X)	PhoneSolicitationsInd
In Person Solicitations	Yes (X)	InPersonSolicitationsInd
Solicitation Of Non Govt Grants	Yes (X)	SolicitationOfNonGovtGrantsInd
Solicitation Of Govt Grants	Yes (X)	SolicitationOfGovtGrantsInd
Special Fundraising Events	Yes (X)	SpecialFundraisingEventsInd
Agrmt Prof Fundraising Acty	Yes (true)	AgrmtProfFundraisingActyInd

Fundraiser Activity Info FundraiserActivityInfoGrp (6 entries)

Address Line1USAddress/AddressLine1Txt	CityUSAddress/CityNm	State AbbreviationUSAddress/StateAbbreviationCd	ZIPUSAddress/ZIPCd	ActivityActivityTxt	Fundraiser Control Of FundsFundraiserControlOfFundsInd	Gross ReceiptsGrossReceiptsAmt	Retained By ContractorRetainedByContractorAmt	Net To OrganizationNetToOrganizationAmt
CX MARKETING LLC
4200 PARLIAMENT PLACE THIRD FLOOR	LANHAM	MD	20706	DIRECT MAIL	false	$4,932,205	$2,604,066	$2,328,139
CHARLES RIVER INTERACTIVE
900 CHELMSFORD ST TOWER III 10TH FL	LOWELL	MA	01851	SOCIAL MEDIA CONSULTING	false		$1,507,088	-$1,507,088
CREATIVE DIRECT RESPONSE
4200 PARLIAMENT PLACE THIRD FLOOR	LANHAM	MA	20706	DIRECT MAIL	false		$1,292,002	-$1,292,002
GRENZEBACH GLIER & ASSOC
200 SOUTH MICHICAN AVE STE 210	CHICAGO	IL	60604	CONSULTING	false		$153,192	-$153,192
IN VOICES LLC
314 ELLIOT ST	MILTON	MA	02186	NEW SPECIAL EVENT AND ONLINE FUNDRAISING STRATEGIES	false		$53,000	-$53,000
HURON CONSULTING GROUP INC
550 W VAN BUREN STREET	CHICAGO	IL	60607	CONSULTING	false		$23,003	-$23,003

Field	Value	IRS element (for citing)
Total Gross Receipts	$4,932,205	TotalGrossReceiptsAmt
Total Retained By Contractors	$5,632,351	TotalRetainedByContractorsAmt
Total Net To Organization	-$700,146	TotalNetToOrganizationAmt
Licensed States	CA	LicensedStatesCd
Licensed States	CO	LicensedStatesCd
Licensed States	CT	LicensedStatesCd
Licensed States	FL	LicensedStatesCd
Licensed States	GA	LicensedStatesCd
Licensed States	AL	LicensedStatesCd
Licensed States	HI	LicensedStatesCd
Licensed States	IL	LicensedStatesCd
Licensed States	KS	LicensedStatesCd
Licensed States	KY	LicensedStatesCd
Licensed States	LA	LicensedStatesCd
Licensed States	ME	LicensedStatesCd
Licensed States	AK	LicensedStatesCd
Licensed States	MD	LicensedStatesCd
Licensed States	MA	LicensedStatesCd
Licensed States	MI	LicensedStatesCd
Licensed States	MN	LicensedStatesCd
Licensed States	MS	LicensedStatesCd
Licensed States	MO	LicensedStatesCd
Licensed States	NV	LicensedStatesCd
Licensed States	NH	LicensedStatesCd
Licensed States	NJ	LicensedStatesCd
Licensed States	NM	LicensedStatesCd
Licensed States	NY	LicensedStatesCd
Licensed States	NC	LicensedStatesCd
Licensed States	ND	LicensedStatesCd
Licensed States	OH	LicensedStatesCd
Licensed States	OK	LicensedStatesCd
Licensed States	OR	LicensedStatesCd
Licensed States	PA	LicensedStatesCd
Licensed States	RI	LicensedStatesCd
Licensed States	SC	LicensedStatesCd
Licensed States	TN	LicensedStatesCd
Licensed States	VA	LicensedStatesCd
Licensed States	AR	LicensedStatesCd
Licensed States	WA	LicensedStatesCd
Licensed States	WV	LicensedStatesCd
Licensed States	WI	LicensedStatesCd

Fundraising Event Information FundraisingEventInformationGrp

Field	Value	IRS element (for citing)
Event1	BMJF WALK	Event1Nm
Gross Receipts Event1	$8,287,160	GrossReceiptsEvent1Amt
Charitable Contri Event1	$8,119,758	CharitableContriEvent1Amt
Gross Revenue Event1	$167,402	GrossRevenueEvent1Amt
Rent Facility Costs Event1	$30,335	RentFacilityCostsEvent1Amt
Food And Beverage Event1	$57,691	FoodAndBeverageEvent1Amt
Entertainment Event1	$7,618	EntertainmentEvent1Amt
Other Direct Expenses Event1	$1,693,547	OtherDirectExpensesEvent1Amt
Event2	DFMC	Event2Nm
Gross Receipts Event2	$8,697,499	GrossReceiptsEvent2Amt
Charitable Contri Event2	$8,602,103	CharitableContriEvent2Amt
Gross Revenue Event2	$95,396	GrossRevenueEvent2Amt
Rent Facility Costs Event2	$151,212	RentFacilityCostsEvent2Amt
Food And Beverage Event2	$23,346	FoodAndBeverageEvent2Amt
Entertainment Event2	$3,068	EntertainmentEvent2Amt
Other Direct Expenses Event2	$892,449	OtherDirectExpensesEvent2Amt
Other Events Total	7	OtherEventsTotalCnt
Gross Receipts Other Events	$6,696,232	GrossReceiptsOtherEventsAmt
Charitable Contri Other Events	$6,478,348	CharitableContriOtherEventsAmt
Gross Revenue Other Events	$217,884	GrossRevenueOtherEventsAmt
Non Cash Prizes Other Events	$1,180	NonCashPrizesOtherEventsAmt
Rent Fclty Costs Other Events	$39,231	RentFcltyCostsOtherEventsAmt
Food And Beverage Other Events	$12,222	FoodAndBeverageOtherEventsAmt
Entertainment Other Events	$30,829	EntertainmentOtherEventsAmt
Oth Direct Expnss Other Events	$865,438	OthDirectExpnssOtherEventsAmt
Gross Receipts Total	$23,680,891	GrossReceiptsTotalAmt
Charitable Contributions Tot	$23,200,209	CharitableContributionsTotAmt
Gross Revenue Total Events	$480,682	GrossRevenueTotalEventsAmt
Non Cash Prizes Total Events	$1,180	NonCashPrizesTotalEventsAmt
Rent Fclty Costs Total Events	$220,778	RentFcltyCostsTotalEventsAmt
Food And Beverage Total Events	$93,259	FoodAndBeverageTotalEventsAmt
Entertainment Total Events	$41,515	EntertainmentTotalEventsAmt
Oth Direct Expnss Total Events	$3,451,434	OthDirectExpnssTotalEventsAmt
Direct Expense Summary Events	$3,808,166	DirectExpenseSummaryEventsAmt
Net Income Summary	-$3,327,484	NetIncomeSummaryAmt

Schedule H IRS990ScheduleH

Field	Value	IRS element (for citing)
Financial Assistance Policy	Yes (true)	FinancialAssistancePolicyInd
Written Policy	Yes (true)	WrittenPolicyInd
All Hospitals Policy	Yes (X)	AllHospitalsPolicyInd
FPG Reference Free Care	Yes (true)	FPGReferenceFreeCareInd
Percent150	Yes (X)	Percent150Ind
FPG Reference Discounted Care	Yes (true)	FPGReferenceDiscountedCareInd
Percent300	Yes (X)	Percent300Ind
Free Care Medically Indigent	Yes (true)	FreeCareMedicallyIndigentInd
Financial Assistance Budget	Yes (true)	FinancialAssistanceBudgetInd
Expenses Exceed Budget	Yes (true)	ExpensesExceedBudgetInd
Unable To Provide Care	false	UnableToProvideCareInd
Annual Community Bnft Report	Yes (true)	AnnualCommunityBnftReportInd
Report Publically Available	Yes (true)	ReportPublicallyAvailableInd

Financial Assistance At Cost Typ FinancialAssistanceAtCostTyp

Field	Value	IRS element (for citing)
Total Community Benefit Expns	$31,891,759	TotalCommunityBenefitExpnsAmt
Direct Offsetting Revenue	$17,322,223	DirectOffsettingRevenueAmt
Net Community Benefit Expns	$14,569,536	NetCommunityBenefitExpnsAmt
Total Expense	0.0043	TotalExpensePct

Unreimbursed Medicaid UnreimbursedMedicaidGrp

Field	Value	IRS element (for citing)
Total Community Benefit Expns	$179,971,700	TotalCommunityBenefitExpnsAmt
Direct Offsetting Revenue	$128,758,473	DirectOffsettingRevenueAmt
Net Community Benefit Expns	$51,213,227	NetCommunityBenefitExpnsAmt
Total Expense	0.0153	TotalExpensePct

Unreimbursed Costs UnreimbursedCostsGrp

Field	Value	IRS element (for citing)
Net Community Benefit Expns	$0	NetCommunityBenefitExpnsAmt
Total Expense	0.0	TotalExpensePct

Total Financial Assistance Typ TotalFinancialAssistanceTyp

Field	Value	IRS element (for citing)
Activities Or Programs	0	ActivitiesOrProgramsCnt
Persons Served	0	PersonsServedCnt
Total Community Benefit Expns	$211,863,459	TotalCommunityBenefitExpnsAmt
Direct Offsetting Revenue	$146,080,696	DirectOffsettingRevenueAmt
Net Community Benefit Expns	$65,782,763	NetCommunityBenefitExpnsAmt
Total Expense	0.0196	TotalExpensePct

Community Health Services CommunityHealthServicesGrp

Field	Value	IRS element (for citing)
Total Community Benefit Expns	$11,599,013	TotalCommunityBenefitExpnsAmt
Direct Offsetting Revenue	$0	DirectOffsettingRevenueAmt
Net Community Benefit Expns	$11,599,013	NetCommunityBenefitExpnsAmt
Total Expense	0.0035	TotalExpensePct

Health Professions Education HealthProfessionsEducationGrp

Field	Value	IRS element (for citing)
Total Community Benefit Expns	$7,823,780	TotalCommunityBenefitExpnsAmt
Direct Offsetting Revenue	$1,422,852	DirectOffsettingRevenueAmt
Net Community Benefit Expns	$6,400,928	NetCommunityBenefitExpnsAmt
Total Expense	0.0019	TotalExpensePct

Subsidized Health Services SubsidizedHealthServicesGrp

Field	Value	IRS element (for citing)
Total Community Benefit Expns	$0	TotalCommunityBenefitExpnsAmt
Direct Offsetting Revenue	$0	DirectOffsettingRevenueAmt
Net Community Benefit Expns	$0	NetCommunityBenefitExpnsAmt
Total Expense	0.0	TotalExpensePct

Research ResearchGrp

Field	Value	IRS element (for citing)
Total Community Benefit Expns	$868,261,747	TotalCommunityBenefitExpnsAmt
Direct Offsetting Revenue	$703,385,267	DirectOffsettingRevenueAmt
Net Community Benefit Expns	$164,876,480	NetCommunityBenefitExpnsAmt
Total Expense	0.0492	TotalExpensePct

Cash And In Kind Contributions CashAndInKindContributionsGrp

Field	Value	IRS element (for citing)
Total Community Benefit Expns	$4,119,762	TotalCommunityBenefitExpnsAmt
Direct Offsetting Revenue	$0	DirectOffsettingRevenueAmt
Net Community Benefit Expns	$4,119,762	NetCommunityBenefitExpnsAmt
Total Expense	0.0012	TotalExpensePct

Total Other Benefits TotalOtherBenefitsGrp

Field	Value	IRS element (for citing)
Activities Or Programs	0	ActivitiesOrProgramsCnt
Persons Served	0	PersonsServedCnt
Total Community Benefit Expns	$891,804,302	TotalCommunityBenefitExpnsAmt
Direct Offsetting Revenue	$704,808,119	DirectOffsettingRevenueAmt
Net Community Benefit Expns	$186,996,183	NetCommunityBenefitExpnsAmt
Total Expense	0.0558	TotalExpensePct

Total Community Benefits TotalCommunityBenefitsGrp

Field	Value	IRS element (for citing)
Activities Or Programs	0	ActivitiesOrProgramsCnt
Persons Served	0	PersonsServedCnt
Total Community Benefit Expns	$1,103,667,761	TotalCommunityBenefitExpnsAmt
Direct Offsetting Revenue	$850,888,815	DirectOffsettingRevenueAmt
Net Community Benefit Expns	$252,778,946	NetCommunityBenefitExpnsAmt
Total Expense	0.0754	TotalExpensePct

Physical Imprv And Housing PhysicalImprvAndHousingGrp

Field	Value	IRS element (for citing)
Net Community Benefit Expns	$0	NetCommunityBenefitExpnsAmt
Total Expense	0.0	TotalExpensePct

Economic Development EconomicDevelopmentGrp

Field	Value	IRS element (for citing)
Net Community Benefit Expns	$0	NetCommunityBenefitExpnsAmt
Total Expense	0.0	TotalExpensePct

Community Support CommunitySupportGrp

Field	Value	IRS element (for citing)
Net Community Benefit Expns	$0	NetCommunityBenefitExpnsAmt
Total Expense	0.0	TotalExpensePct

Environmental Improvements EnvironmentalImprovementsGrp

Field	Value	IRS element (for citing)
Net Community Benefit Expns	$0	NetCommunityBenefitExpnsAmt
Total Expense	0.0	TotalExpensePct

Leadership Development LeadershipDevelopmentGrp

Field	Value	IRS element (for citing)
Net Community Benefit Expns	$0	NetCommunityBenefitExpnsAmt
Total Expense	0.0	TotalExpensePct

Coalition Building CoalitionBuildingGrp

Field	Value	IRS element (for citing)
Net Community Benefit Expns	$0	NetCommunityBenefitExpnsAmt
Total Expense	0.0	TotalExpensePct

Health Improvement Advocacy HealthImprovementAdvocacyGrp

Field	Value	IRS element (for citing)
Net Community Benefit Expns	$0	NetCommunityBenefitExpnsAmt
Total Expense	0.0	TotalExpensePct

Workforce Development WorkforceDevelopmentGrp

Field	Value	IRS element (for citing)
Net Community Benefit Expns	$0	NetCommunityBenefitExpnsAmt
Total Expense	0.0	TotalExpensePct

Other Communtity Building Acty OtherCommuntityBuildingActyGrp

Field	Value	IRS element (for citing)
Net Community Benefit Expns	$0	NetCommunityBenefitExpnsAmt
Total Expense	0.0	TotalExpensePct

Total Communtity Building Acty TotalCommuntityBuildingActyGrp

Field	Value	IRS element (for citing)
Activities Or Programs	0	ActivitiesOrProgramsCnt
Persons Served	0	PersonsServedCnt
Total Community Benefit Expns	$0	TotalCommunityBenefitExpnsAmt
Direct Offsetting Revenue	$0	DirectOffsettingRevenueAmt
Net Community Benefit Expns	$0	NetCommunityBenefitExpnsAmt
Total Expense	0.0	TotalExpensePct

Field	Value	IRS element (for citing)
Bad Debt Expense Reported	Yes (true)	BadDebtExpenseReportedInd
Bad Debt Expense	$5,200,375	BadDebtExpenseAmt
Bad Debt Expense Attributable	$52,004	BadDebtExpenseAttributableAmt
Reimbursed By Medicare	$555,850,588	ReimbursedByMedicareAmt
Cost Of Care Reimbursed By Medcr	$625,978,472	CostOfCareReimbursedByMedcrAmt
Medicare Surplus Or Shortfall	-$70,127,884	MedicareSurplusOrShortfallAmt

Costing Methodology Used CostingMethodologyUsedGrp

Field	Value	IRS element (for citing)
Other	Yes (X)	OtherInd

Field	Value	IRS element (for citing)
Written Debt Collection Policy	Yes (true)	WrittenDebtCollectionPolicyInd
Financial Assistance Prvsn	Yes (true)	FinancialAssistancePrvsnInd
Hospital Facilities	1	HospitalFacilitiesCnt

Hospital Facilities HospitalFacilitiesGrp

Field	Value	IRS element (for citing)
Facility	1	FacilityNum

Business Name BusinessName

Field	Value	IRS element (for citing)
Business Name Line1	DANA-FARBER CANCER INSTITUTE INC	BusinessNameLine1Txt

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	450 BROOKLINE AVE	AddressLine1Txt
City	BOSTON	CityNm
State Abbreviation	MA	StateAbbreviationCd
ZIP	02215	ZIPCd

Field	Value	IRS element (for citing)
Website Address	WWW.DANA-FARBER.ORG	WebsiteAddressTxt
State License	2335	StateLicenseNum
Licensed Hospital	Yes (X)	LicensedHospitalInd
Teaching Hospital	Yes (X)	TeachingHospitalInd
Research Facility	Yes (X)	ResearchFacilityInd

Hospital Fclty Policies Prctc HospitalFcltyPoliciesPrctcGrp

Hospital Facility Name HospitalFacilityName

Field	Value	IRS element (for citing)
Business Name Line1	DANA-FARBER CANCER INSTITUTE INC	BusinessNameLine1Txt

Field	Value	IRS element (for citing)
Facility	1	FacilityNum
First Licensed CY Or PY	false	FirstLicensedCYOrPYInd
Tax Exempt Hospital CY Or PY	false	TaxExemptHospitalCYOrPYInd
CHNA Conducted	Yes (true)	CHNAConductedInd
Community Definition	Yes (X)	CommunityDefinitionInd
Community Demographics	Yes (X)	CommunityDemographicsInd
Existing Resources	Yes (X)	ExistingResourcesInd
How Data Obtained	Yes (X)	HowDataObtainedInd
Community Health Needs	Yes (X)	CommunityHealthNeedsInd
Other Health Issues	Yes (X)	OtherHealthIssuesInd
Community Hlth Needs Id Process	Yes (X)	CommunityHlthNeedsIdProcessInd
Consulting Process	Yes (X)	ConsultingProcessInd
Prior CHNA Impact	Yes (X)	PriorCHNAImpactInd
CHNA Conducted	22	CHNAConductedYr
Take Into Account Others Input	Yes (true)	TakeIntoAccountOthersInputInd
CHNA Conducted With Other Fclts	false	CHNAConductedWithOtherFcltsInd
CHNA Conducted With Non Fclts	false	CHNAConductedWithNonFcltsInd
CHNA Report Widely Available	Yes (true)	CHNAReportWidelyAvailableInd
Rpt Available On Own Website	Yes (X)	RptAvailableOnOwnWebsiteInd
Own Website URL	https://www.dana-farber.org/community-health	OwnWebsiteURLTxt
Paper Copy Public Inspection	Yes (X)	PaperCopyPublicInspectionInd
Implementation Strategy Adopt	Yes (true)	ImplementationStrategyAdoptInd
Implementation Strategy Adpt	22	ImplementationStrategyAdptYr
Strategy Posted Website	Yes (true)	StrategyPostedWebsiteInd
Strategy Website URL	https://www.dana-farber.org/community-health/community-health-needs-assessment	StrategyWebsiteURLTxt
Organization Incur Excise Tax	false	OrganizationIncurExciseTaxInd
Elig Criteria Explained	Yes (true)	EligCriteriaExplainedInd
FPG Family Incm Lmt Free Dscnt	Yes (X)	FPGFamilyIncmLmtFreeDscntInd
FPG Family Incm Lmt Free Care	150.0	FPGFamilyIncmLmtFreeCarePct
FPG Family Incm Lmt Dscnt Care	300.0	FPGFamilyIncmLmtDscntCarePct
Medical Indigency Criteria	Yes (X)	MedicalIndigencyCriteriaInd
Explained Basis	Yes (true)	ExplainedBasisInd
App Financial Asst Expln	Yes (true)	AppFinancialAsstExplnInd
Described Info	Yes (X)	DescribedInfoInd
Described Suprt Doc	Yes (X)	DescribedSuprtDocInd
Provided Hospital Contact	Yes (X)	ProvidedHospitalContactInd
Includes Publicity Measures	Yes (true)	IncludesPublicityMeasuresInd
FAP Available On Website	Yes (X)	FAPAvailableOnWebsiteInd
FAP Available On Website URL	https://dfci.widen.net/s/krrkjnz9sq/financial-assistance-application-2025.pdf	FAPAvailableOnWebsiteURLTxt
FAP App Available On Website	Yes (X)	FAPAppAvailableOnWebsiteInd
FAP App Available On Website URL	https://dfci.widen.net/s/krrkjnz9sq/financial-assistance-application-2025.pdf	FAPAppAvailableOnWebsiteURLTxt
FAP Summary On Website	Yes (X)	FAPSummaryOnWebsiteInd
FAP Summary On Website URL	https://dfci.widen.net/s/krrkjnz9sq/financial-assistance-application-2025.pdf	FAPSummaryOnWebsiteURLTxt
FAP Avlbl On Request No Charge	Yes (X)	FAPAvlblOnRequestNoChargeInd
FAP App Avlbl On Request No Chrg	Yes (X)	FAPAppAvlblOnRequestNoChrgInd
FAP Sum Avlbl On Request No Chrg	Yes (X)	FAPSumAvlblOnRequestNoChrgInd
Notified FAP Copy Bill Display	Yes (X)	NotifiedFAPCopyBillDisplayInd
Communtity Notified FAP	Yes (X)	CommuntityNotifiedFAPInd
FAP Translated	Yes (X)	FAPTranslatedInd
FAP Actions On Nonpayment	Yes (true)	FAPActionsOnNonpaymentInd
Permit No Actions	Yes (X)	PermitNoActionsInd
Collection Activities	false	CollectionActivitiesInd
Provided Written Notice	Yes (X)	ProvidedWrittenNoticeInd
Made Effort Orally Notify	Yes (X)	MadeEffortOrallyNotifyInd
Processed FAP Application	Yes (X)	ProcessedFAPApplicationInd
Nondis Emergency Care Policy	Yes (true)	NondisEmergencyCarePolicyInd
Look Back Medicaid Medcr Prvt	Yes (X)	LookBackMedicaidMedcrPrvtInd
Amounts Generally Billed	false	AmountsGenerallyBilledInd
Gross Charges	false	GrossChargesInd

Supplemental Information SupplementalInformationGrp (3 entries)

Form And Line ReferenceFormAndLineReferenceDesc	ExplanationExplanationTxt
Schedule H, Part V, Section B, Line 5 Facility , 1	Facility , 1 - Dana-Farber Cancer Institute ("DFCI"). IN 2022, DFCI'S BOARD OF TRUSTEES APPROVED THE 2022-2025 CANCER-FOCUSED COMMUNITY HEALTH NEEDS ASSESSMENT (CHNA) AND IMPLEMENTATION PLAN TO ENSURE THAT OUR COLLECTIVE EFFORTS HAVE THE MAXIMUM POSSIBLE IMPACT WITHIN THE INSTITUTE'S PRIORITY NEIGHBORHOODS. DANA-FARBER'S COMMUNITY BENEFITS OFFICE RETAINED HEALTH RESOURCES IN ACTION (HRIA), A NON-PROFIT PUBLIC HEALTH CONSULTANCY ORGANIZATION IN BOSTON, TO UNDERTAKE A COMPREHENSIVE ASSESSMENT OF THE HEALTH NEEDS WITHIN OUR PRIORITY COMMUNITIES, INCLUDING HOW THOSE NEEDS ARE CURRENTLY BEING ADDRESSED AND WHERE THERE ARE OPPORTUNITIES TO ADDRESS THESE NEEDS IN THE FUTURE. DANA-FARBER'S 2022-2025 CHNA BUILDS OFF PREVIOUS EFFORTS TO GAIN A GREATER UNDERSTANDING OF THE HEALTH ISSUES FACING BOSTON RESIDENTS ACROSS THE CONTINUUM OF CANCER CARE, WITH A FOCUS ON THE CITY OF BOSTON AND DANA-FARBER'S PRIORITY NEIGHBORHOODS FOR COMMUNITY BENEFITS WORK - DORCHESTER, ROXBURY, MISSION HILL, JAMAICA PLAIN, AND MATTAPAN. THE CHNA INTEGRATES KEY FINDINGS FROM THE CITYWIDE CHNA AND DELVES MORE DEEPLY INTO THE NEEDS AND EXPERIENCES OF CANCER PATIENTS, SURVIVORS, AND CAREGIVERS THROUGHOUT THE CANCER CONTINUUM, EXPLORING BEHAVIORS AND HEALTH OUTCOMES AROUND PREVENTION, SCREENING, TREATMENT, AND SURVIVORSHIP USING SOCIAL DETERMINANTS OF HEALTH AND HEALTH EQUITY FRAMEWORKS. THE ONGOING COVID-19 PANDEMIC, WHICH HAS RESULTED IN SIGNIFICANT CHANGES AND INEQUITIES IN HEALTH, THE ECONOMY, AND THE WORKFORCE, HAS BEEN AN IMPORTANT AND EVOLVING BACKDROP TO THIS CHNA. THE PURPOSE OF THE CHNA IS TO ADVANCE COMMUNITY EFFORTS IN PRIORITY AREAS BY: ASSESSING CANCER BURDEN IN THE COMMUNITY AS WELL AS ACCESS TO AND AVAILABILITY OF CANCER-RELATED SERVICES; IDENTIFYING KEY AREAS OF SIGNIFICANT COMMUNITY NEED AND VULNERABLE POPULATIONS; EXAMINING THE IMPACT AND ROLE OF SOCIAL DETERMINANTS OF HEALTH; AND FACILITATING THE DEVELOPMENT OF MULTI-YEAR IMPLEMENTATION STRATEGIES TO GUIDE DFCI'S COMMUNITY HEALTH INITIATIVES AND COMMUNITY INVESTMENTS. IN ADDITION TO IDENTIFYING BROAD HEALTH ISSUES FACING RESIDENTS, THE 2022-2025 CHNA INVESTIGATES THE FULL CONTINUUM OF CANCER CARE; IT EXPLORES DIFFERENT ASPECTS OF CARE FROM INITIAL SCREENING TO TREATMENT AND CULMINATES WITH CONSIDERATIONS OF SURVIVORSHIP. THE BOSTON CHNA-CHIP COLLABORATIVE (THE COLLABORATIVE) WAS CREATED AND LAUNCHED BY SEVERAL STAKEHOLDERS-COMMUNITY ORGANIZATIONS, HEALTH CENTERS, COMMUNITY DEVELOPMENT CORPORATIONS, HOSPITALS, AND THE BOSTON PUBLIC HEALTH COMMISSION. IN 2019, THE COLLABORATIVE CONDUCTED THE FIRST LARGE-SCALE COLLABORATIVE CITYWIDE COMMUNITY HEALTH NEEDS ASSESSMENT (BOSTON CHNA) AND COMMUNITY HEALTH IMPROVEMENT PLANNING (BOSTON CHIP) PROCESS. THE GOALS OF THE BOSTON CHNA ARE TO SYSTEMATICALLY IDENTIFY THE HEALTH-RELATED NEEDS, STRENGTHS, AND RESOURCES OF COMMUNITIES TO INFORM FUTURE PLANNING, UNDERSTAND THE CURRENT HEALTH STATUS OF BOSTON OVERALL AND ITS SUB-POPULATIONS WITHIN THEIR SOCIAL CONTEXT, AND MEET REGULATORY REQUIREMENTS FOR SEVERAL INSTITUTIONS, ORGANIZATIONS, AND AGENCIES (E.G. IRS REQUIREMENTS FOR NON-PROFIT HOSPITALS, PUBLIC HEALTH ACCREDITATION BOARD FOR HEALTH DEPARTMENTS). DURING THE CITYWIDE CHNA: AS A MEMBER OF THE STEERING COMMITTEE, DANA-FARBER WORKED CLOSELY WITH MEMBERS OF THE COLLABORATIVE TO CONDUCT A ROBUST DATA COLLECTION AND A COMMUNITY ENGAGEMENT PROCESS. THE COVID-19 PANDEMIC PLAYED AN IMPORTANT BACKDROP DURING THE ASSESSMENTS PHASE. THE 2022 CHNA'S ALSO EXPLORED HOW THE PANDEMIC AND RACIAL INJUSTICES HAVE AFFECTED COMMUNITY HEALTH NEEDS. DANA-FARBER IS COMMITTED TO MEETING THE HEALTH NEEDS OF MEDICALLY UNDERSERVED POPULATIONS AND RECOGNIZES THAT MANY OF THE POPULATIONS THAT DANA-FARBER FOCUSED ON IN ITS 2022 CHNA HAVE BEEN DISPROPORTIONATELY IMPACTED BY THE COVID-19 PANDEMIC. GIVEN THE UNPRECEDENTED NATURE OF THE COVID-19 PANDEMIC, IT IS CRITICAL NOW, MORE THAN EVER, TO UNDERSTAND COMMUNITY NEEDS, EXPERIENCES, AND OPPORTUNITIES FOR THE FUTURE. SECONDARY DATA FOR THIS REPORT COME FROM A VARIETY OF SOURCES. DATA SOURCES INCLUDE THE BOSTON BEHAVIORAL RISK FACTOR SURVEILLANCE SURVEY (BBRFSS), THE U.S. CENSUS, THE MASSACHUSETTS CANCER REGISTRY, AND VITAL RECORDS. AS PART OF THE BBRFSS, A SEPARATE COVID-19 HEALTH EQUITY SURVEY WAS CONDUCTED IN DECEMBER 2020/JANUARY 2021 BY THE BOSTON PUBLIC HEALTH COMMISSION TO BETTER UNDERSTAND EXPERIENCES AMONG RESIDENTS WHO HAVE BEEN MOST IMPACTED BY THE PANDEMIC. DATA FROM THIS COVID-19 HEALTH EQUITY SURVEY ARE ALSO INCLUDED IN THIS REPORT. THE RESEARCH AND EVALUATION OFFICE AT THE BOSTON PUBLIC HEALTH COMMISSION CONDUCTED THE DATA ANALYSIS FOR NEARLY ALL THE SECONDARY DATA ON HEALTH INDICATORS IN THIS REPORT (E.G., LIFESTYLE BEHAVIORS, SCREENING BEHAVIORS, CANCER INCIDENCE, CANCER MORTALITY). ANALYSES ARE PRESENTED AS FREQUENCIES (PERCENTAGES) AND RATES THROUGHOUT THE REPORT. ADDITIONAL DATA SOURCES INCLUDE PRESENTATIONS AND REPORTS REGARDING THE SOCIAL DETERMINANTS OF HEALTH, HEALTH OUTCOMES, AND HEALTH CARE EXPERIENCES FOR SEVERAL COMMUNITIES OF COLOR AND SEXUAL AND GENDER MINORITY POPULATIONS. THESE SOURCES INCLUDE: A 2022 PRESENTATION BY DR. DON S. DIZON, "DON'T ASK, CAN'T COUNT. ADDRESSING THE INVISIBILITY OF THE SGM COMMUNITY ACROSS THE CANCER TRAJECTORY EXPERIENCE FENWAY HEALTH AND BLACK BOSTON COVID-19 COALITION 2022 REPORT, "LEARNING FROM BOSTON'S BLACK COMMUNITY WHAT SUPPORTS ITS HEALTH, RESILIENCE, AND WELLBEING" (REFERRED TO HEREAFTER AS THE "BLACK BOSTON 2022 REPORT"); AND THE MASSACHUSETTS DEPARTMENT OF PUBLIC HEALTH'S WOMEN'S HEALTH NETWORK 2019 REPORT, "ASSESSMENT OF COLORECTAL CANCER SCREENING ATTITUDES AND PRACTICES AMONG THE ASIAN COMMUNITY IN MASSACHUSETTS."
Schedule H, Part V, Section B, Line 5 Facility , 2	Facility , 2 - Dana-Farber Cancer Institute ("DFCI"). DANA-FARBER DESIGNED A QUALITATIVE KEY INFORMANT SURVEY. THIS SURVEY WAS FIELDED WITH CANCER SURVIVORS AND REPRESENTATIVES FROM ORGANIZATIONS THAT SERVE INDIVIDUALS ACROSS THE CANCER CONTINUUM. THE SURVEY AIMED TO UNDERSTAND THEIR EXPERIENCES WITH CANCER PREVENTION, CANCER CARE, AND SURVIVORSHIP; RECOMMENDATIONS FOR CANCER AND CHRONIC DISEASE PREVENTION SERVICES AND RESOURCES; THE INFLUENCE OF THE COVID-19 PANDEMIC ON ACCESS TO CANCER SCREENING AND HEALTH CARE; POTENTIAL FACILITATORS TO INCREASE CANCER SCREENING; AND RECOMMENDATIONS FOR ADDRESSING GAPS IN SERVICES AND RESOURCES FOR CANCER SURVIVORS. OF 27 PEOPLE CONTACTED, A TOTAL OF 13 CANCER SURVIVORS AND COMMUNITY STAKEHOLDERS REPRESENTING COMMUNITY-BASED, PUBLIC HEALTH, AND HEALTH CARE ORGANIZATIONS COMPLETED THIS QUALITATIVE SURVEY. DFCI WORKED WITH A VARIETY OF PARTNERS TO GATHER PRIMARY QUALITATIVE DATA THROUGH FOCUS GROUPS AND INTERVIEW DISCUSSIONS. DFCI MADE A CONCERTED EFFORT TO ENGAGE WITH POPULATIONS AND COMMUNITIES THAT HAVE BEEN HISTORICALLY MARGINALIZED. ALTOGETHER, 8 FOCUS GROUPS WITH 69 PARTICIPANTS (CAREGIVERS, PATIENTS/SURVIVORS) AND 4 INTERVIEW DISCUSSIONS WERE CONDUCTED SPECIFICALLY FOR ITS CHNA. KEY THEMES FROM TWO ADDITIONAL DATA SOURCES WERE ALSO ANALYZED AND ARE INCORPORATED INTO THIS CHNA. FIRST, THE BOSTON BREAST CANCER EQUITY COALITION (BBCEC) SHARED KEY THEMES FROM 9 INTERVIEWS CONDUCTED WITH SMALL, LOCAL NON-PROFIT ORGANIZATIONS WHO SUPPORT BIPOC COMMUNITIES. SECOND, THE BOSTON PUBLIC HEALTH COMMISSION ALSO SHARED KEY FINDINGS FROM A FOCUS GROUP CONDUCTED WITH THEIR 10-MEMBER RACIAL HEALTH EQUITY ADVISORY COMMITTEE (RHEAC) TO GARNER INPUT TO INFORM THE CREATION OF A LUNG CANCER COMMUNICATION CAMPAIGN. THIS REPORT ALSO INTEGRATES FINDINGS FROM DATA COLLECTED AS PART OF THE 2022 BOSTON CHNA-CHIP COLLABORATIVE'S PROCESS. THE COLLABORATIVE'S COMMUNITY ENGAGEMENT WORK GROUP FACILITATED 29 VIRTUAL AND IN-PERSON FOCUS GROUP DISCUSSIONS WITH A TOTAL OF 309 RESIDENTS WHO HAVE BEEN DISPROPORTIONATELY BURDENED BY SOCIAL, ECONOMIC, AND HEALTH CHALLENGES INCLUDING: YOUTH AND ADOLESCENTS, OLDER ADULTS, PERSONS WITH DISABILITIES, LOW-RESOURCED INDIVIDUALS AND FAMILIES, LGBTQIA+ POPULATIONS, RACIALLY/ETHNICALLY DIVERSE POPULATIONS (E.G., AFRICAN AMERICAN, LATINO, HAITIAN, CAPE VERDEAN, VIETNAMESE, CHINESE), LIMITED-ENGLISH SPEAKERS, IMMIGRANT AND ASYLEE COMMUNITIES, FAMILIES AFFECTED BY INCARCERATION AND/OR VIOLENCE, AND VETERANS. SOME FOCUS GROUPS WERE CONDUCTED IN LANGUAGES OTHER THAN ENGLISH, INCLUDING SPANISH, CHINESE, AND VIETNAMESE. COLLABORATIVE MEMBERS ALSO CONDUCTED KEY INFORMANT INTERVIEWS WITH 62 INDIVIDUALS. THESE INTERVIEWEES INCLUDED LEADERS AND STAFF FROM PUBLIC HEALTH, HEALTH CARE, BEHAVIORAL HEALTH, THE FAITH COMMUNITY, IMMIGRANT SERVICES, HOUSING ORGANIZATIONS, ECONOMIC DEVELOPMENT, COMMUNITY DEVELOPMENT, RACIAL JUSTICE ORGANIZATIONS, SOCIAL SERVICE ORGANIZATIONS, EDUCATION, COMMUNITY COALITIONS, THE BUSINESS COMMUNITY, CHILDCARE CENTERS, ELECTED GOVERNMENT OFFICES, AND OTHERS. THE STRATEGIES AND GOALS OUTLINED IN OUR 2022-2025 CHNA IMPLEMENTATION PLAN ARE A NATURAL CONTINUATION OF THE EFFORTS IDENTIFIED IN OUR 2020-2023 PLAN AND ARE DESIGNED TO ADVANCE AND STRENGTHEN OUR EXISTING COMMUNITY-BASED INITIATIVES WHILE ALSO SEEKING TO ADDRESS THE SOCIAL DETERMINANTS OF HEALTH THROUGH COLLABORATIVE PARTNERSHIPS.
Schedule H, Part V, Section B, Line 11 Facility , 1	Facility , 1 - Dana-Farber Cancer Institute ("DFCI"). DFCI CAPTURED AND ADDRESSED ALL THE NEEDS IDENTIFIED IN THE COMMUNITY HEALTH NEEDS ASSESSMENT (CHNA) AND THE ACCOMPANYING IMPLEMENTATION PLAN. A FULL DESCRIPTION OF OUR PROGRAMS IS AVAILABLE ON OUR WEBSITE BOTH IN THE COMMUNITY HEALTH NEEDS ASSESSMENT REPORT AND IN THE COMMUNITY HEALTH IMPLEMENTATION PLAN. CANCER REMAINS A LEADING CAUSE OF DEATH IN BOSTON. WHILE THE CHNA FINDINGS INDICATE THAT COLLECTIVE EFFORTS TO ADVANCE CANCER SCREENING AND PREVENTION ARE MAKING A DIFFERENCE, THE OVERALL BURDEN OF CANCER ACROSS ALL TYPES IS SIGNIFICANT AND MORE EFFORT IS NEEDED TO REDUCE THE CANCER BURDEN AND ADDRESS DISPARITIES. DANA-FARBER RECOGNIZES THAT OUR EFFORTS MUST GO BEYOND CANCER CARE AND TREATMENT, AND AS SUCH, WE WILL CONTINUE OUR UNWAVERING COMMITMENT TO REDUCING THE CANCER BURDEN AND PROMOTING SURVIVORSHIP. WE REMAIN COMMITTED TO EDUCATING THE COMMUNITY AND RAISING AWARENESS ABOUT THE IMPORTANCE OF CANCER PREVENTION, OUTREACH, SCREENING, EARLY DETECTION, CLINICAL TRIALS AND SURVIVORSHIP. IN ADDITION, WE WILL CONTINUE TO CONDUCT A BROAD SCOPE OF COMMUNITY-BASED RESEARCH AND EVIDENCE-BASED INTERVENTIONS THROUGH COLLABORATIVE WORK IN LOCAL NEIGHBORHOODS AND THROUGHOUT THE REGION. OUR EXPERTISE AS A COMPREHENSIVE CANCER CENTER LEADS US TO FOCUS LARGELY ON REDUCING CANCER INCIDENCE AND MORTALITY AMONG MEDICALLY UNDERSERVED POPULATIONS THROUGH OUR CLINICAL COMMUNITY SCREENING AND OUTREACH PROGRAMS, WHICH INCLUDE MOBILE MAMMOGRAPHY AND BREAST HEALTH EDUCATION, SKIN CANCER EDUCATION AND SCREENING, HPV EDUCATION AND VACCINATION, TOBACCO CESSATION AND INCREASING AWARENESS ABOUT SURVIVORSHIP IN COMMUNITIES OF COLOR. WE RECOGNIZE THAT OUR PRIORITY NEIGHBORHOODS ARE ALSO DEALING DISPROPORTIONATELY WITH CHALLENGING SITUATIONS RELATED TO SOCIAL AND ECONOMIC FACTORS, SUCH AS LIMITED EMPLOYMENT OPPORTUNITIES, SUBSTANCE ABUSE AND OPIOID ADDICTION, LOW EDUCATION LEVELS, LACK OF AFFORDABLE HOUSING, AND COMMUNITY VIOLENCE. WE WORK ON THESE BROADER ISSUES BY ADVOCATING AND BY PARTNERING WITH LOCAL COALITIONS AND COMMUNITY-BASED ORGANIZATIONS SUCH AS THE MASS HEALTH EQUITY COMPACT LED BY THE MASSACHUSETTS LEAGUE OF COMMUNITY HEALTH CENTERS. SIGNIFICANT PROGRESS HAS BEEN MADE IN ADVANCING THE GOALS SET IN OUR 2020-2023 CHNA IMPLEMENTATION PLAN. SUMMARIZED BELOW ARE EXAMPLES OF KEY ACCOMPLISHMENTS FROM THE PAST THREE YEARS, WHICH DEMONSTRATE THE COLLECTIVE IMPACT OF OUR WORK. OUR IMPACT IS GREATLY STRENGTHENED BY EMBEDDING PROGRAMMING AND SERVICES INTO THE FABRIC OF THE COMMUNITIES WE SERVE. * LAUNCHED NEW STATE OF THE ART MOBILE MAMMOGRAPHY VAN EQUIPPED WITH NEW TOMOSYNTHESIS IMAGING TECHNOLOGY. * PROVIDED 4,029 MAMMOGRAMS ON DANA-FARBER'S MAMMOGRAPHY VAN AND 1,735 MAMMOGRAMS AT DANA-FARBER'S MAMMOGRAPHY SUITE AT WHITTIER STREET HEALTH CENTER IN ROXBURY. * SUCCESSFULLY LAUNCHED NEW COMMUNITY-FACING PATIENT NAVIGATION PROGRAM, WHICH WAS PILOTED IN THE BREAST, THORACIC, AND GASTROINTESTINAL DISEASE CENTERS AND WILL BE EMBEDDED INTO ALL MAJOR CLINICAL AREAS AT DANA-FARBER. * AWARDED THE FIRST ROUND OF FUNDING FOR DANA-FARBER'S ACCESS TO SERVICES GRANTS TO 12 NONPROFIT ORGANIZATIONS IN GREATER BOSTON AND COMMITTED $1 MILLION DOLLARS TO THE HEALTHY NEIGHBORHOODS EQUITY FUND TO ADDRESS HOUSING NEEDS IN GREATER BOSTON. * COMMITTED $500K TO HEALTHY RETAIL & COMMERCE FUND TO SUPPORT HEALTHY FOOD ACCESS AND $250K TO THE BOSTON LOCAL INITIATIVES SUPPORT CORPORATION (LISC BOSTON) SMALL BUSINESS GROWTH FUND TO SUPPORT ECONOMIC EMPOWERMENT AND GROW BUSINESSES OWNED BY BLACK, LATINO, AND INDIGENOUS ENTREPRENEURS AND OTHER PEOPLE OF COLOR. * CONTINUED TO PROVIDE STREAMLINED DIAGNOSIS, TREATMENT, AND EDUCATION FOR MEDICALLY UNDERSERVED PATIENTS WITH SUSPECTED MALIGNANCIES THROUGHOUT THE CONTINUUM OF CARE THROUGH DANA-FARBER'S CANCER CARE EQUITY PROGRAM (CCEP) AT FEDERALLY QUALIFIED COMMUNITY HEALTH CENTERS. SINCE PROGRAM INCEPTION IN 2012, THE PROGRAM HAS SEEN OVER 692 PATIENTS AS NEW CONSULTS AND 507 PATIENTS IN FOLLOW-UP VISITS. * PROVIDED 348 INDIVIDUAL TOBACCO CESSATION COUNSELING SESSIONS TO 126 PATIENTS. * 104 PARTICIPANTS (84%) REPORTED THAT THEY WERE ABLE TO REDUCE THEIR TOTAL NUMBER OF CIGARETTES SMOKED PER DAY, AND 37 (28%) REPORTED BEING ABLE TO QUIT COMPLETELY. PROVIDED NICOTINE REPLACEMENT THERAPY (NICOTINE PATCHES AND LOZENGES) AND GIFT CARDS TO 49 GIFT PATIENTS ENROLLED IN THE SMOKING CESSATION PROGRAM TO ENCOURAGE INDIVIDUALS TO REDUCE THEIR TOBACCO USAGE AND QUIT SMOKING. * ENGAGED 2,233 RESIDENTS IN SUN SAFETY EDUCATION AND SKIN CANCER SCREENING. MADE CALLS TO 264 PARTICIPANTS FOR FOLLOW-UP, WITH 128 REFERRED FOR BIOPSY. * CONTINUED TO LEAD STATEWIDE MASSACHUSETTS HPV COALITION IN PARTNERSHIP WITH TEAM MAUREEN. LAUNCHED UPDATED DENTAL TOOLKIT, AVAILABLE IN 7 LANGUAGES. CONVENED APPROXIMATELY 250 MEDICAL AND DENTAL PROVIDERS, PUBLIC HEALTH PROFESSIONALS, AND COMMUNITY ADVOCATES THROUGH ANNUAL HPV-RELATED CANCER SUMMIT TO DISSEMINATE LATEST RESEARCH AND BEST PRACTICES. * PARTNERED WITH UNION CAPITAL BOSTON AND THE DANA-FARBER/HARVARD CANCER CENTER TO ENGAGE OVER 800 COMMUNITY RESIDENTS THROUGH VIRTUAL EDUCATION NIGHTS FOCUSED ON CANCER PREVENTION TOPICS. DANA-FARBER CANCER INSTITUTE \|COMMUNITY HEALTH IMPLEMENTATION PLAN 9. * LAUNCHED A NEW PARTNERSHIP WITH MYHEALTHFAIR.ORG TO INCREASE VIRTUAL EDUCATION AND OUTREACH WITH THE LOCAL SPANISH-SPEAKING COMMUNITY.

Field	Value	IRS element (for citing)
Facility	9	FacilityNum

Oth Hlth Care Fclts Not Hospital OthHlthCareFcltsNotHospitalGrp

Oth Hlth Care Fclts OthHlthCareFcltsGrp (10 entries)

Address Line1USAddress/AddressLine1Txt	CityUSAddress/CityNm	State AbbreviationUSAddress/StateAbbreviationCd	ZIPUSAddress/ZIPCd	FacilityFacilityTxt	Address Line2USAddress/AddressLine2Txt
DFBWCC AT SOUTH SHORE HOSPITAL
101 COLUMBIAN STREET	SOUTH WEYMOUTH	MA	02190	SATELLITE
DFBWCC AT MILFORD REGIONAL MEDICAL CENTER
20 PROSPECT STREET	MILFORD	MA	01757	SATELLITE
DFCI - CHESTNUT HILL
300 BOYLSTON STREET	NEWTON	MA	02459	SATELLITE
DFCI - MERRIMACK VALLEY
5 BRANCH STREET	METHUEN	MA	01844	SATELLITE
DFNH ONCOLOGY-HEMATOLOGY
ELLIOTT MED CENTER 40 BUTTRICK RD S	LONDONDERRY	NH	03053	SATELLITE	TE B
DFCI AT ST ELIZABETH'S MEDICAL CNTR
CUSHING PAVILION 736 CAMBRIDGE STRE	BRIGHTON	MA	02135	SATELLITE	ET
DFCI - LIBBEY PARK
51 PERFORMANCE DRIVE	WEYMOUTH	MA	02189	SATELLITE
DFCI - MOBILE MAMMOGRAPHY SERVICE
450 BROOKLINE AVENUE	BOSTON	MA	02215	SATELLITE
DFCI - WHITTIER STREET HEALTH CENTER
1290 TREMONT STREET	ROXBURY	MA	02120	SATELLITE
DANA-FARBER CANCER INSTITUTE - FOXBOROUGH
22 PATRIOT PLACE	FOXBOROUGH	MA	02035	SATELLITE

Supplemental Information Detail SupplementalInformationDetail (20 entries)

Form And Line ReferenceFormAndLineReferenceDesc	ExplanationExplanationTxt
Schedule H, Part I, Line 3c Patient education of eligibility for assistance	IN ADDITION TO DETERMINING ELIGIBILITY FOR DISCOUNTED CARE BASED ON FAMILY INCOME, DFCI OFFERS ASSISTANCE TO PATIENTS WHO HAVE EXCESSIVE MEDICAL BILLS (EXCEEDING 30-40% OF FAMILY INCOME).
Schedule H, Part I, Line 6a Community information	THE COMMUNITY BENEFIT REPORT WAS COMPLETED BY DFCI AND IS ANNUALLY PROVIDED TO THE MASSACHUSETTS ATTORNEY GENERAL'S OFFICE, WHERE IT IS THEN MADE PUBLIC ON ITS WEBSITE.
Schedule H, Part I, Line 7 State filing of community benefit report	DFCI'S STATE COST REPORT WAS USED TO DEVELOP THE INSTITUTE'S COST TO CHARGE RATIO THAT WAS APPLIED TO CHARITY CARE CHARGES TO DETERMINE THE COST OF FINANCIAL ASSISTANCE (LINE 7A). LINE 7B REFLECTS THE SPECIFIC LOSS INCURRED FOR THE INSTITUTE'S MEDICAID ACTIVITY. THE INSTITUTE IS A PREEMINENT PROVIDER OF HEALTH TRAINING TO HEALTH PROFESSIONALS WHO DESIRE TRAINING IN THE SKILLS NECESSARY TO TREAT CANCER PATIENTS. THE INSTITUTE TRAINS PHYSICIANS, SCIENTISTS, MEDICAL STUDENTS AND INDIVIDUALS LOOKING TO CREATE A CAREER IN THE FIELD OF CANCER. THE AMOUNT REPORTED AS HEALTH TRAINING REPRESENT COSTS IN EXCESS OF AMOUNTS REIMBURSED BY THIRD PARTY PAYERS SUCH AS TRAINING GRANT REVENUES AND DIRECT MEDICAL EDUCATION PAYMENTS FROM THE MEDICARE PROGRAM. DEPARTMENT LEADERS SUBMIT EXPENDITURES TO COMMUNITY BENEFITS ALONG WITH A DESCRIPTION OF THE SERVICES PROVIDED TO MEDICALLY UNDERSERVED POPULATIONS. LINE 7F EXPENDITURES ARE REVIEWED BY LEADERSHIP AND IN PARTNERSHIP WITH DFCI'S OFFICE OF FINANCE, THE EXPENDITURES ARE APPROVED. THE AMOUNTS ARE CAPTURED IN THREE BUCKETS - CB EXPENDITURES (ALL PROGRAMS); LEVERAGED FUNDS (THOSE FUNDS SUPPORTED IN FULL OR PART THROUGH GRANTS/DONATIONS) AND COMMUNITY SPONSORSHIPS.
Schedule H, Part V SECTION A & D	DFCI'S MAIN CAMPUS IS LOCATED 450 BROOKLINE AVE., BOSTON, MA, 02115. DFCI'S SATELLITE LOCATIONS (BELOW) EACH OPERATE UNDER THE SAME HOSPITAL LICENSE. DANA-FARBER/BRIGHAM AND WOMEN'S CANCER CENTER AT MILFORD HOSPITAL, 20 PROSPECT STREET, MILFORD, MA 01757 DANA-FARBER/BRIGHAM AND WOMEN'S CANCER CENTER AT SOUTH SHORE HOSPITAL, 101 COLUMBIAN STREET, SOUTH WEYMOUTH, MA 02190 DANA-FARBER AT ST. ELIZABETH'S MEDICAL CENTER, 736 CAMBRIDGE STREET, CUSHING PAVILION, 5TH FLOOR, BRIGHTON, MA 02135 DANA-FARBER CANCER INSTITUTE - CHESTNUT HILL, 300 BOYLSTON STREET, NEWTON, MA 02459 DANA-FARBER CANCER INSTITUTE - MERRIMACK VALLEY, 5 BRANCH STREET, METHUEN, MA 01844 DANA-FARBER CANCER INSTITUTE - FOXBOROUGH, 22 PATRIOT PLACE, FOXBOROUGH, MA, 02035 DANA-FARBER CANCER INSTITUTE - LIBBEY PARK, 51 PERFORMANCE DRIVE, WEYMOUTH, MA 02189 DANA-FARBER CANCER INSTITUTE - MOBILE MAMMOGRAPHY SERVICE, 450 BROOKLINE AVENUE, BOSTON, MA 02215 DANA-FARBER CANCER INSTITUTE - WHITTIER STREET HEALTH CENTER, 1290 TREMONT STREET, ROXBURY, MA 02120 DANA-FARBER/NEW HAMPSHIRE ONCOLOGY HEMATOLOGY ALSO OPERATES A CLINICAL LOCATION AT 40 BUTTRICK ROAD, SUITE B, LONDONDERRY, NH 03053.
Schedule H, Part III Section A, Lines 2 and 3 - Bad Debt Expense	IN CALCULATING BAD DEBT EXPENSE, DFCI USES A COMBINATION OF ACTUAL BAD DEBT WRITE OFFS AND HISTORICAL BAD DEBT FACTORS IN DETERMINING WHICH CURRENT ACCOUNTS RECEIVABLE ARE NOT LIKELY TO BE COLLECTED. ADDITIONALLY, DFCI DETERMINES THE AMOUNT OF BAD DEBT ATTRIBUTABLE TO INDIVIDUALS WHO ARE ELIGIBLE FOR FINANCIAL ASSISTANCE BASED ON A HISTORICAL ESTIMATE OF THE PERCENTAGE OF PATIENTS THAT HAVE QUALIFIED FOR FINANCIAL ASSISTANCE, WHICH IS APPLIED AGAINST TOTAL BAD DEBT.
Schedule H, Part V, Section B, Line 20d Billing and collections	DANA-FARBER DOES NOT ENGAGE IN PRESUMPTIVE ELIGIBILITY FOR ITS PATIENT FINANCIAL ASSISTANCE POLICY (FAP). THROUGH ITS PARTICIPATION IN THE MASSACHUSETTS HEALTH SAFETY NET, THE STATE SPONSORED UNCOMPENSATED PROGRAM, DANA-FARBER FIRST RELIES ON DEMONSTRATION OF INELIGIBILITY FOR MASSHEALTH PROGRAMS, SUCH AS HEALTH SAFETY NET, OR SIMILAR OUT OF STATE MEDICAID PROGRAMS, FROM PATIENTS APPLYING FOR ASSISTANCE. UPON DETERMINATION BY THE STATE AGENCY, DANA-FARBER WILL CONSIDER EACH CASE INDIVIDUALLY AND RELIES ON THE COMPLETION OF THE PATIENT FINANCIAL ASSISTANCE APPLICATION ("PFA APPLICATION") AND PROVISION OF NECESSARY SUPPORTING DOCUMENTATION.
Schedule H, Part V, Section B, Line 22 Charges to FAP eligible individuals	DEPENDING ON A PATIENT'S FINANCIAL SITUATION, FAP-ELIGIBLE PATIENTS WERE CHARGED BETWEEN 0% TO 30% OF BILLED CHARGES, WHICH WAS NOT MORE THAN THE AGB. IN FY24, DFCI DETERMINED AGB ON AN ANNUAL BASIS USING THE "LOOK-BACK METHOD," DESCRIBED UNDER TREASURY REGULATION SECTION 1.501(R)-5(B)(1). SPECIFICALLY, DFCI'S ANNUAL AGB PERCENTAGE WAS EQUAL TO SUM OF ALL GROSS CHARGES DURING THE PRIOR FISCAL YEAR DIVIDED BY CLAIMS PAID IN CONNECTION WITH THOSE CHARGES. FOR PURPOSES OF THE AGB CALCULATION, CLAIMS PAID INCLUDED CLAIMS FOR EMERGENCY AND MEDICALLY NECESSARY CARE PAID BY BOTH MEDICARE FEE-FOR-SERVICE AND ALL PRIVATE HEALTH INSURERS AS PRIMARY PAYERS, TOGETHER WITH ANY ASSOCIATED PORTIONS OF THESE CLAIMS PAID BY MEDICARE BENEFICIARIES OR INSURED INDIVIDUALS IN THE FORM OF CO-PAYMENTS, CO-INSURANCE OR DEDUCTIBLES.
Schedule H, Part I, Line 6a Community benefit report prepared by related organization	DANA-FARBER CANCER INSTITUTE ("DFCI")
Schedule H, Part I, Line 7 Bad Debt Expense excluded from financial assistance calculation	5200375
Schedule H, Part III, Line 4 Bad debt expense - financial statement footnote	CONSISTENT WITH THE INSTITUTE'S MISSION, CARE IS PROVIDED TO PATIENTS REGARDLESS OF THEIR ABILITY TO PAY. THE INSTITUTE HAS DETERMINED IT HAS PROVIDED IMPLICIT PRICE CONCESSIONS TO UNINSURED PATIENTS AND PATIENTS WITH OTHER UNINSURED BALANCES (E.G. COPAYS AND DEDUCTIBLES). THE IMPLICIT PRICE CONCESSIONS INCLUDED IN ESTIMATING THE TRANSACTION PRICE REPRESENT THE DIFFERENCE BETWEEN AMOUNTS BILLED TO PATIENTS AND THE AMOUNTS THE INSTITUTE EXPECTS TO COLLECT BASED ON ITS COLLECTION HISTORY WITH THOSE PATIENTS. PATIENTS WHO MEET THE INSTITUTE'S CRITERIA FOR CHARITY CARE ARE PROVIDED CARE WITHOUT CHARGE OR AT AMOUNTS LESS THAN ESTABLISHED RATES. THE INSTIUTE HAS DETERMINED THAT IT HAS PROVIDED SUFFICIENT IMPLICIT PRICE CONCESSIONS FOR THESE ACCOUNTS. PRICE CONCESSIONS, INCLUDING CHARITY CARE, ARE NOT REPORTED AS REVENUE.
Schedule H, Part III, Line 8 Community benefit & methodology for determining medicare costs	THE MEDICARE COST ON LINE 6 COMES FROM THE MEDICARE COST REPORT AND IS BASED ON MEDICARE'S COST FINDING PRINCIPLES AND METHODOLOGIES. WE STRONGLY BELIEVE THAT THE ENTIRE AMOUNT OF THE SHORTFALL OF $70,127,884 SHOULD BE TREATED AS A COMMUNITY BENEFIT AS THIS REPRESENTS THE INSTITUTE'S COMMITMENT TO THE ELDERLY AND DISABLED COMMUNITY BY PROVIDING SERVICES THAT ARE NOT REIMBURSED.
Schedule H, Part III, Line 9b Collection practices for patients eligible for financial assistance	WITHIN DFCI'S CREDIT AND COLLECTIONS POLICY THERE ARE PROVISIONS THAT DESCRIBE COLLECTION PRACTICES TO BE FOLLOWED FOR PATIENTS WHO ARE KNOWN TO QUALIFY FOR CHARITY CARE OR FINANCIAL ASSISTANCE IN ACCORDANCE WITH FEDERAL AND MASSACHUSETTS LAW.
Schedule H, Part V, Section B, Line 16a FAP website	- DANA-FARBER CANCER INSTITUTE, INC.: Line 16a URL: https://dfci.widen.net/s/krrkjnz9sq/financial-assistance-application-2025.pdf;
Schedule H, Part V, Section B, Line 16b FAP Application website	- DANA-FARBER CANCER INSTITUTE, INC.: Line 16b URL: https://dfci.widen.net/s/krrkjnz9sq/financial-assistance-application-2025.pdf;
Schedule H, Part V, Section B, Line 16c FAP plain language summary website	- DANA-FARBER CANCER INSTITUTE, INC.: Line 16c URL: https://dfci.widen.net/s/krrkjnz9sq/financial-assistance-application-2025.pdf;
Schedule H, Part VI, Line 2 Needs assessment	DANA-FARBER CANCER INSTITUTE CONTINUOUSLY ASSESSES THE COMMUNITY NEEDS THROUGH OUR PARTICIPATION IN COMMUNITY COALITIONS, TASK FORCES, WORKING GROUPS AND DIRECT COMMUNICATION WITH THE COMMUNITY RESIDENTS THAT SERVE ON OUR EXTERNAL ADVISORY COMMITTEE AND ON OUR PATIENT AND FAMILY ADVISORY BOARD. A FULL DESCRIPTION OF OUR COMMUNITY ENGAGEMENT PROCESS CAN BE FOUND ON OUR WEBSITE BOTH IN THE COMMUNITY HEALTH NEEDS ASSESSMENT REPORT AND IN THE COMMUNITY HEALTH IMPLEMENTATION PLAN.
Schedule H, Part VI, Line 3 Patient education of eligibility for assistance	DFCI IS COMMITTED TO OFFERING FINANCIAL ASSISTANCE TO ELIGIBLE PATIENTS WHO DO NOT HAVE THE ABILITY TO PAY FOR THEIR MEDICAL SERVICES IN WHOLE OR IN PART. IN ORDER TO ACCOMPLISH THIS CHARITABLE GOAL, DFCI WIDELY PUBLICIZES ITS PATIENT FINANCIAL ASSISTANCE (PFA) POLICY WITHIN ITS FACILITIES, IN DIRECT COMMUNICATIONS WITH PATIENTS AND IN THE COMMUNITIES THAT IT SERVES, PARTICULARLY IN THE COMMUNITIES WITH THE GREATEST UNMET HEALTH NEEDS. THE PFA POLICY, A PLAIN LANGUAGE PFA SUMMARY AND THE PFA APPLICATION ARE POSTED ON DFCI'S WEBSITE IN ENGLISH AND SPANISH. IN ADDITION, INFORMATION ABOUT THE PFA IS PROVIDED TO ALL PATIENTS AT REGISTRATION AND/OR ADMISSION, AND IS AVAILABLE UPON REQUEST, WITHOUT CHARGE, THROUGH A DFCI FINANCIAL COUNSELOR, CUSTOMER SERVICE REPRESENTATIVE, OR BY MAIL. FOLLOWING CARE, ALL BILLING STATEMENTS SENT TO A PATIENT INDICATE HOW THE PATIENT CAN OBTAIN INFORMATION ABOUT THE PFA POLICY. IN COLLABORATION WITH DFCI'S COMMUNITY PARTNERS, INFORMATION ABOUT THE FAP IS SHARED WITH RESIDENTS OF DFCI'S PRIORITY NEIGHBORHOODS. EFFORTS TO NOTIFY COMMUNITY MEMBERS MOST LIKELY TO REQUIRE ASSISTANCE INCLUDE DISTRIBUTING PLAIN LANGUAGE SUMMARIES OF THIS POLICY TO LOCAL COMMUNITY HEALTH CENTERS AND OTHER NON-PROFIT ORGANIZATIONS.
Schedule H, Part VI, Line 4 Community information	DANA-FARBER SERVES THE COMMUNITY OF EASTERN MASSACHUSETTS AND NEW ENGLAND, INCLUDING THE COMMUNITIES SURROUNDING ITS PRIMARY LOCATION IN BOSTON AND ITS SATELLITE LOCATIONS IN MILFORD, MASSACHUSETTS, WEYMOUTH, MASSACHUSETTS, BRIGHTON, MASSACHUSETTS, NEWTON, MASSACHUSETTS, METHUEN, MASSACHUSETTS, FOXBOROUGH, MASSACHUSETTS AND LONDONDERRY, NEW HAMPSHIRE. DANA-FARBER'S COMMUNITY INCLUDES ADULTS AND CHILDREN WITH CANCER OR AT RISK OF DEVELOPING CANCER, AND THEIR FAMILIES. DANA-FARBER FOCUSES ITS COMMUNITY OUTREACH EFFORTS ON ITS PRIORITY BOSTON NEIGHBORHOODS OF ROXBURY, MISSION HILL, DORCHESTER, MATTAPAN AND JAMAICA PLAIN (WHICH COLLECTIVELY COMPRISE 39% OF BOSTON'S OVERALL POPULATION). TWO OF BOSTON'S MOST POPULATED NEIGHBORHOODS ARE DANA-FARBER PRIORITY NEIGHBORHOODS-DORCHESTER WITH 122,598 RESIDENTS, FOLLOWED BY ROXBURY WITH 49,028. WHITE RESIDENTS NOW MAKE UP LESS THAN HALF OF THE CITY'S RACIAL AND ETHNIC COMPOSITION (46%). BLACK OR AFRICAN AMERICAN RESIDENTS WERE THE SECOND LARGEST RACIAL AND ETHNIC GROUP (23%), FOLLOWED BY HISPANICS (18%) AND ASIANS (9%). THERE IS SUBSTANTIAL VARIATION IN THE DEMOGRAPHIC MAKEUP OF DFCI'S PRIORITY NEIGHBORHOOD, WITH NEARLY THREE-QUARTERS OF MATTAPAN RESIDENTS AND HALF OF ROXBURY RESIDENTS IDENTIFYING AS BLACK OR AFRICAN AMERICAN. AMONG DANA-FARBER'S PRIORITY NEIGHBORHOODS, ROXBURY AND JAMAICA PLAIN HAVE THE LARGEST HISPANIC POPULATIONS WITH 29% AND 24% RESPECTIVELY, WHILE MISSION HILL AND DORCHESTER HAVE THE LARGEST ASIAN POPULATIONS AMONG THE PRIORITY NEIGHBORHOODS WITH 14% AND 10% RESPECTIVELY. THE MEDIAN INCOMES OF DANA-FARBER'S PRIORITY COMMUNITIES ARE GENERALLY MUCH LOWER THAN BOSTON OVERALL, WITH ROXBURY AT A MEDIAN INCOME OF $25,254, MISSION HILL AT $35,020, AND MATTAPAN AT $42,206. MANY OF DANA-FARBER'S PRIORITY NEIGHBORHOODS, ROXBURY AND MATTAPAN, ARE MORE LIKELY TO HAVE A GREATER POPULATION AT THE LOWER END OF THE INCOME SPECTRUM. RESIDENTS IN DANA-FARBER'S PRIORITY NEIGHBORHOODS APPEAR TO EXPERIENCE HIGHER RATES OF POVERTY THAN BOSTON OVERALL. FEMALE HEADED HOUSEHOLDS ARE ESPECIALLY VULNERABLE, WITH 45% OF ROXBURY FEMALE-HEADED HOUSEHOLDS LIVING BELOW THE POVERTY LINE. DESPITE ITS STATEWIDE REACH AND SERVICES PROVIDED THROUGH OUR SATELLITE OPERATIONS IN WEYMOUTH, ALLSTON/BRIGHTON, MILFORD, AND FOXBOROUGH, DANA-FARBER'S PRIORITIZATION OF THESE FIVE NEIGHBORHOODS WITHIN ITS LOCAL SERVICE AREA REFLECTS A COMMITMENT TO REDUCING DISPARITIES IN CANCER CARE AND IMPROVING THE HEALTH AND WELL-BEING OF NEIGHBORHOOD RESIDENTS. THROUGH OUR COLLABORATIVE APPROACH, THE SATELLITE LOCATIONS HAVE AGREED TO LEVERAGE EACH OTHER'S CANCER CONTROL EXPERTISE TO EXPAND AND STRENGTHEN OUR PROGRAMS SUCH AS BRINGING CANCER PREVENTION EFFORTS IN SPANISH TO THE ALLSTON/BRIGHTON AREA.
Schedule H, Part VI, Line 5 Promotion of community health	DANA-FARBER'S 2022-2025 COMMUNITY HEALTH NEEDS ASSESSMENT AND IMPLEMENTATION PLAN PROVIDE A ROBUST DESCRIPTION OF OUR COMPREHENSIVE CANCER CONTROL PROGRAMS AND SERVICES. THE REPORT ALSO PROVIDES A SUMMARY OF ACCOMPLISHMENTS FROM OUR LAST NEEDS ASSESSMENT AND SETS FORTH OUR COMMITMENT TO ADDRESSING THE NEW OPPORTUNITIES TO REDUCE THE CANCER BURDEN IN MEDICALLY UNDERSERVED COMMUNITIES IN BOSTON. THE REPORTS CAN BE FOUND USING THE FOLLOWING LINKS: COMMUNITY HEALTH NEEDS ASSESSMENT - https://dfci.widen.net/s/rgj28wdsgj/cancer-chna-report-2022.pdf IMPLEMENTATION PLAN - https://dfci.widen.net/s/lkdq7ffjgz/community-health-implementation-plan-2022-25.pdf IN ADDITION, DFCI FURTHERS ITS EXEMPT PURPOSES BY PROMOTING THE HEALTH OF THE COMMUNITY THROUGH DEVOTING THE VAST MAJORITY OF ITS SURPLUS FUNDS TO INSTITUTIONAL SUPPORTED RESEARCH (140 MILLION), BY PROVIDING FINANCIAL ASSISTANCE TO PATIENTS UNABLE TO AFFORD CARE AND BY MAINTAINING A COMMUNITY BOARD.
Schedule H, Part VI, Line 7 State filing of community benefit report	MA

Schedule I IRS990ScheduleI

Field	Value	IRS element (for citing)
Grant Records Maintained	Yes (true)	GrantRecordsMaintainedInd

Recipient Table RecipientTable (30 entries)

Address Line1USAddress/AddressLine1Txt	CityUSAddress/CityNm	State AbbreviationUSAddress/StateAbbreviationCd	ZIPUSAddress/ZIPCd	Recipient EINRecipientEIN	IRC SectionIRCSectionDesc	Cash GrantCashGrantAmt	Purpose Of GrantPurposeOfGrantTxt	Address Line2USAddress/AddressLine2Txt
CITY OF BOSTON
City Hall Plaza	Boston	MA	02114	046001380	115	$1,651,544	Community Support
HARVARD UNIVERSITY
60 Oxford St	Cambridge	MA	02138	042103580	501(c)(3)	$1,433,691	Cancer Research and Development
Alternative for Community and Environment with MPHA
2201 Washington St	Roxbury	MA	02119	043228509	501(c)(3)	$200,000	Community Support	Ste 302
FamilyAid Boston
3815 Washington St	Boston	MA	02130	042105756	501(c)(3)	$181,362	Community Support
BOSTON ATHLETIC ASSOCIATION
40 TRINITY PLACE 4TH FL	BOSTON	MA	02216	046111707	501(c)(3)	$130,000	Community Support
Green Roots
90 Everett Ave 3rd FL	Chelsea	MA	02150	812718273	501(c)(3)	$100,000	Community Support	STE 10
Project Bread
145 Border St	East Boston	MA	02128	042931195	501(c)(3)	$99,834	Community Support
FRIENDS OF DANA FARBER
450 Brookline Ave	Boston	MA	02215	371613621	501(c)(3)	$50,000	Cancer Research and Development
LEUKEMIA & LYMPHOMA SOCIETY INC
1311 Mamaroneck Ave	WHITE PLANES	NY	10605	135644916	501(c)(3)	$50,000	Cancer Research and Development
TEAM MAUREEN
PO Box 422	NORTH Falmouth	MA	021203400	452473500	501(c)(3)	$30,000	Community Support
PROSTATE HEALTH EDUCATION NETWORK INC
500 Victory Rd 4Th Fl	Quincy	MA	02453	331042404	501(c)(3)	$30,000	Cancer Research and Development
ONCOLOGY NURSING FOUNDATION
125 ENTERPRISE DRIVE	PITTSBURGH	PA	15275	251410081	501(c)(3)	$21,000	Cancer Research and Development
ROXBURY COMMUNITY COLLEGE FOUNDATION
1234 COLUMBUS AVE	ROXBURY	MA	021203400	222536037	501(c)(3)	$15,000	Community Support
THE BREAST CANCER RESEARCH FOUNDATION
60 EAST 56TH ST	NEW YORK	NY	10022	133727250	501(c)(3)	$15,000	Cancer Research and Development	8TH FL
ELLIE FUND INC
200 RESERVOIR ST STE 300	NEEDHAM	MA	02494	043280390	501(c)(3)	$12,500	Community Support
2LIFE COMMUNITIES INC
30 WALLINGFORD RD	BRIGHTON	MA	021354753	042478888	501(c)(3)	$10,000	Community Support
AMERICAN CANCER SOCIETY
250 Williams St	Atlanta	GA	30303	131788491	501(c)(3)	$10,000	Cancer Research and Development
CANCER RESEARCH INSTITUTE
29 Broadway 4th Floor	New York	NY	10006	131837442	501(c)(3)	$10,000	Cancer Research and Development
CRISTO REY BOSTON HIGH SCHOOL INC
100 SAVIN HILL AVENUE	BOSTON	MA	02125	562438544	501(c)(3)	$10,000	Community Support
FORCE FACING OUR RISK OF CANCER EMPOWERED
16057 TAMPA PALMS BLVD W PMB 373	TAMPA	FL	33647	650927702	501(c)(3)	$10,000	Community Support
JOE ANDRUZZI FOUNDATION INC
49 PLAIN ST	NORTH ATTLEBORO	MA	02760	252017043	501(c)(3)	$10,000	Cancer Research and Development
MASSACHUSETTS LEAGUE OF COMMUNITY
40 COURT ST 10TH FL	BOSTON	MA	02108	042507409	501(c)(3)	$10,000	Community Support
NEHI INC
50 MILK ST 16TH FL	BOSTON	MA	02109	010624865	501(c)(3)	$10,000	Community Support
SUMMER SEARCH
304 12TH ST STE 4A	OAKLAND	CA	94607	680200138	501(c)(3)	$10,000	Community Support
SUSAN G KOMEN BREAST CANCER FOUNDATION
13770 NOEL RD	DALLAS	TX	75380	751835298	501(c)(3)	$10,000	Cancer Research and Development
UNITED NEGRO COLLEGE FUND INC
1805 7TH ST NW	WASHINGTON	DC	20001	131624241	501(c)(3)	$10,000	Community Support
BOYS & GIRLS CLUB OF BOSTON
200 High St Ste 3B	BOSTON	MA	02110	042103922	501(c)(3)	$7,500	Community Support
MASSACHUSETTS PUBLIC HEALTH ASSOCIATION
50 FEDERAL ST 8TH FL	BOSTON	MA	02110	042326503	501(c)(3)	$7,500	Community Support
NATIONAL CANCER CENTER INC
400 MONTAUK HIGHWAY 100	WEST ISLIP	NY	11795	131919715	501(c)(3)	$7,000	Cancer Research and Development
HEALTH CARE FOR ALL
30 WINTER ST	BOSTON	MA	02108	043071598	501(c)(3)	$6,000	Community Support

Field	Value	IRS element (for citing)
Total501c3 Org	29	Total501c3OrgCnt
Total Other Org	1	TotalOtherOrgCnt

Grants Other Asst To Indiv In US GrantsOtherAsstToIndivInUSGrp (2 entries)

Grant TypeGrantTypeTxt	RecipientRecipientCnt	Cash GrantCashGrantAmt	Non Cash AssistanceNonCashAssistanceDesc	Non Cash AssistanceNonCashAssistanceAmt	Valuation Method UsedValuationMethodUsedDesc
Patient Assistance	856	$910,218	Miscellaneous
Patient Assistance	3295		ASST LIVING & TRAVEL	$2,356,748	FMV

Supplemental Information Detail SupplementalInformationDetail

Field	Value	IRS element (for citing)
Form And Line Reference	Schedule I, Part I, Line 2 Procedures for monitoring use of grant funds.	FormAndLineReferenceDesc
Explanation	PROCEDURES FOR MONITORING THE USE OF GRANT FUNDS ALL GRANTS AND DONATIONS TO DOMESTIC ORGANIZATIONS WERE GIVEN TO 501(C)(3) ORGANIZATIONS TO FULFILL THEIR MISSIONS, OR GOVERNMENT ENTITIES. ALL GRANT FUNDS TO INDIVIDUALS WERE PROVIDED BASED ON EITHER (AND ONLY) 1) MEANS-TESTED FINANCIAL NEED, OR 2) CLINICALLY DETERMINED IMPROVEMENT TO QUALITY-OF-LIFE.	ExplanationTxt

Schedule J IRS990ScheduleJ

Field	Value	IRS element (for citing)
Idemnification Gross Up Pmts	Yes (X)	IdemnificationGrossUpPmtsInd
Written Policy Ref T And E Expnss	Yes (true)	WrittenPolicyRefTAndEExpnssInd
Substantiation Required	false	SubstantiationRequiredInd
Compensation Committee	Yes (X)	CompensationCommitteeInd
Independent Consultant	Yes (X)	IndependentConsultantInd
Form990 Of Other Organizations	Yes (X)	Form990OfOtherOrganizationsInd
Compensation Survey	Yes (X)	CompensationSurveyInd
Board Or Committee Approval	Yes (X)	BoardOrCommitteeApprovalInd
Severance Payment	false	SeverancePaymentInd
Supplemental Nonqual Rtr Plan	Yes (true)	SupplementalNonqualRtrPlanInd
Equity Based Comp Arrngm	false	EquityBasedCompArrngmInd
Comp Based On Revenue Of Flng Org	false	CompBasedOnRevenueOfFlngOrgInd
Comp Bsd On Rev Related Orgs	false	CompBsdOnRevRelatedOrgsInd
Comp Bsd Net Earns Flng Org	false	CompBsdNetEarnsFlngOrgInd
Comp Bsd Net Earns Rltd Orgs	false	CompBsdNetEarnsRltdOrgsInd
Any Non Fixed Payments	Yes (true)	AnyNonFixedPaymentsInd
Initial Contract Exception	false	InitialContractExceptionInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (19 entries)

TitleTitleTxt	Base Compensation Filing OrgBaseCompensationFilingOrgAmt	Compensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmt	Bonus Filing OrganizationBonusFilingOrganizationAmount	Bonus Related OrganizationsBonusRelatedOrganizationsAmt	Other Compensation Filing OrgOtherCompensationFilingOrgAmt	Other Compensation Rltd OrgsOtherCompensationRltdOrgsAmt	Deferred Compensation Flng OrgDeferredCompensationFlngOrgAmt	Deferred Comp Rltd OrgsDeferredCompRltdOrgsAmt	Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmt	Nontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmt	Total Compensation Filing OrgTotalCompensationFilingOrgAmt	Total Compensation Rltd OrgsTotalCompensationRltdOrgsAmt	Comp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmt	Comp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt
Laurie H Glimcher MD
Trustee, President & CEO	$1,413,095	$0	$540,784	$0	$151,265	$0	$336,307	$0	$18,374	$0	$2,459,825	$0	$0	$0
John O Chesley ESQ
Counsel	$416,000	$0	$40,000	$0	$0	$0	$0	$0	$0	$0	$456,000	$0	$0	$0
William Hahn MD PHD
COO & EVP	$946,800	$0	$270,701	$0	$82,227	$0	$46,440	$0	$3,560	$0	$1,349,728	$0	$0	$0
Michael L Reney
CFO & Assistant Treasurer	$804,672	$0	$229,890	$0	$64,377	$0	$46,439	$0	$3,638	$0	$1,149,016	$0	$0	$0
Jennifer Willcox ESQ
Asst Secretary & General Counsel	$602,917	$0	$38,871	$0	$50,346	$0	$48,450	$0	$34,769	$0	$775,353	$0	$0	$0
Sylvia A Bartel RPh MHP
SR. VP of Pharmacy & CPO	$323,377	$0	$33,279	$0	$3,609	$0	$46,440	$0	$39,598	$0	$446,303	$0	$0	$0
Craig A Bunnell MD MPH MBA
Chief Medical Officer	$743,304	$0	$145,018	$0	$75,634	$0	$46,440	$0	$6,958	$0	$1,017,354	$0	$0	$0
Melany Duval
SVP & Chief Philanthropy Officer	$740,190	$0	$141,508	$0	$56,630	$0	$46,440	$0	$21,890	$0	$1,006,658	$0	$0	$0
Benjamin Ebert MD PhD
CHAIR OF MEDICAL ONCOLOGY	$107,371	$0	$0	$0	$101,729	$0	$11,858	$0	$3,269	$0	$224,227	$0	$0	$0
Wendy Gettleman
VP of Facilities Management & Real Estate	$351,671	$0	$35,371	$0	$2,555	$0	$46,011	$0	$43,607	$0	$479,215	$0	$0	$0
Kevin Haigis PHD
Chief Scientific Officer	$536,718	$0	$102,595	$0	$28,515	$0	$46,440	$0	$4,357	$0	$718,625	$0	$0	$0
Maria Megdal
SVP Chief Administrative Officer	$537,124	$0	$102,907	$0	$30,314	$0	$46,440	$0	$22,088	$0	$738,873	$0	$0	$0
Jeffrey Meyerhardt MD MPH
Chief Clinical Research Officer	$554,093	$0	$124,366	$0	$41,658	$0	$46,440	$0	$43,128	$0	$809,685	$0	$0	$0
Barrett J Rollins MD PHD
Sr. Advisor to President & CEO	$512,515	$0	$0	$0	$34,135	$0	$46,440	$0	$11,520	$0	$604,610	$0	$0	$0
Scott Armstrong MD PHD
Chair of Pediatric Oncology	$632,226	$0	$121,650	$0	$65,815	$0	$46,440	$0	$34,682	$0	$900,813	$0	$0	$0
Michael Constantine MD
Milford Med Dir-Hematology/Oncology	$698,250	$0	$45,603	$0	$56,999	$0	$46,440	$0	$43,226	$0	$890,518	$0	$0	$0
Bruce Johnson MD
Sr. Advisor to President & CEO	$566,358	$0	$126,473	$0	$56,510	$0	$46,146	$0	$27,392	$0	$822,879	$0	$0	$0
Elizabeth Liebow
Former Key Employee	$251,819	$0	$83,157	$0	$870,895	$0	$34,471	$0	$17,109	$0	$1,257,451	$0	$0	$0
Robert Soiffer MD
Chair Executive Committee for Clinical Programs	$622,510	$0	$162,977	$0	$53,752	$0	$46,440	$0	$22,615	$0	$908,294	$0	$0	$0

Supplemental Information Detail SupplementalInformationDetail (3 entries)

Form And Line ReferenceFormAndLineReferenceDesc	ExplanationExplanationTxt
Schedule J, Part I, Line 1a Tax indemnification and gross-up payments	FOR THE FOLLOWING, BENEFITS REPORTED IN PART VII INCLUDES GROSS-UP PAYMENTS FOR AN EMPLOYEE RECOGNITION PROGRAM AWARD: 5 KEY EMPLOYEES 3 OFFICERS 1 HIGHEST-COMPENSATED EMPLOYEES
Schedule J, Part I, Line 4b Supplemental nonqualified retirement plan	THE FOLLOWING INDIVIDUALS PARTICIPATE IN 457(F) PLANS ESTABLISHED BY DFCI; TAXABLE AMOUNTS ARE INCLUDED IN REPORTABLE COMPENSATION IN SCHEDULE J, PART II, COLUMN (B)(III): Laurie Glimcher, MD - $136,433 William Hahn, MD, Ph.D - $77,325 Michael Reney - $59,475 Craig A. Bunnell, MD - $52,110 Melany Duval - $51,728 Michael Constantine, MD - $47,475 Scott Armstrong, MD - $38,700 Robert Soiffer, MD - $37,113 Bruce Johnson, MD - $30,269 Jeffrey Meyerhardt, MD - $29,453 Maria Megdal - $26,382 Kevin Haigis, Ph.D - $26,177 Barrett J. Rollins, MD, Ph.D - $22,983
Schedule J, Part I, Line 7 Non-fixed payments	DURING THE YEAR, THE CEO, COO, CFO, GENERAL COUNSEL, CERTAIN KEY EMPLOYEES AND HIGHEST COMPENSATED EMPLOYEES WERE ELIGIBLE TO RECEIVE AN INCENTIVE PAYMENT, A PORTION OF WHICH HAS A NON-FIXED PAYMENT PAYABLE AT THE DISCRETION OF THE CEO AND IN THE CASE OF THE CEO, THE BOARD OF TRUSTEES. THE MAXIMUM NON-FIXED PORTION OF THESE INCENTIVE PAYMENTS IS BETWEEN 8% (CEO - 40% MAX, OF THAT 32% TEAM, 8% INDIVIDUAL) AND 4% (SVP - 20% MAX, OF THAT 16% TEAM AND 4% INDIVIDUAL; VP - 10% MAX, OF THAT 6% TEAM AND 4% INDIVIDUAL; AND (EVP - 30% MAX, OF THAT 24% TEAM AND 6% INDIVIDUAL). OTHER REPORTABLE COMPENSATION INCLUDES LOAN FORGIVENESS AND CURRENT YEAR VESTING AMOUNTS IN DANA-FARBER INSTITUTE'S SUPPLEMENTAL NONQUALIFIED RETIREMENT PLAN.

Schedule K IRS990ScheduleK

Tax Exempt Bonds Issues TaxExemptBondsIssuesGrp (4 entries)

Bond ReferenceBondReferenceCd	Bond Issuer EINBondIssuerEIN	Bond IssuedBondIssuedDt	Issue PriceIssuePriceAmt	PurposePurposeDesc	DefeasedDefeasedInd	On Behalf Of IssuerOnBehalfOfIssuerInd	Pool FinancingPoolFinancingInd	CUSIPCUSIPNum
MASSACHUSETTS DEVELOPMENT FINANCE AGENCY
A	043431814	2015-08-03	$92,500,000	THE BOND ISSUE WAS USED TO REFUND SERIES L-1 BONDS ISSUED ON 5/22/2008.	false	false	false
MASSACHUSETTS DEVELOPMENT FINANCE AGENCY
B	043431814	2016-06-23	$281,786,480	(SEE STATEMENT)	false	false	false	05758XNZ0
MASSACHUSETTS DEVELOPMENT FINANCE AGENCY
C	043431814	2019-09-03	$60,255,238	THE BOND ISSUE WAS USED TO REFUND SERIES K BONDS ISSUED ON 5/22/2008.	false	false	false	57584YVC0
MASSACHUSETTS DEVELOPMENT FINANCE AGENCY
D	043431814	2021-07-28	$57,500,000	THE BOND ISSUE WAS USED TO REFUND SERIES L-2A BONDS ISSUED ON 7/2/2012.	false	false	false

Tax Exempt Bonds Proceeds TaxExemptBondsProceedsGrp (4 entries)

Bond ReferenceBondReferenceCd	Total ProceedsTotalProceedsAmt	Other Spent ProceedsOtherSpentProceedsAmt	Substantial CompletionSubstantialCompletionYr	Refunding Tax Exempt BondsRefundingTaxExemptBondsInd	Refunding Taxable BondsRefundingTaxableBondsInd	Final Allocation MadeFinalAllocationMadeInd	Adequate Books And Rec MaintAdequateBooksAndRecMaintInd	Capitalized InterestCapitalizedInterestAmt	Issuance Costs From ProceedsIssuanceCostsFromProceedsAmt	Capital ExpendituresCapitalExpendituresAmt
A	$92,500,000	$92,500,000	2015	Yes (true)	false	Yes (true)	Yes (true)
B	$282,914,006		2019	false	false	Yes (true)	Yes (true)	$1,127,526	$2,486,701	$279,299,779
C	$60,255,238	$59,091,281	2019	Yes (true)	false	Yes (true)	Yes (true)		$1,163,957
D	$57,500,000	$57,500,000	2021	Yes (true)	false	Yes (true)	Yes (true)

Tax Exempt Bonds Private Bus Use TaxExemptBondsPrivateBusUseGrp (4 entries)

Bond ReferenceBondReferenceCd	Owning Bond Financed PropertyOwningBondFinancedPropertyInd	Any Lease ArrangementsAnyLeaseArrangementsInd	Mgmt Contract Bond Fincd PropMgmtContractBondFincdPropInd	Engage Bond Counsel ContractsEngageBondCounselContractsInd	Any Research AgreementsAnyResearchAgreementsInd	Engage Bond Counsel ResearchEngageBondCounselResearchInd	Bond Iss Meet Prvt Sec Pymt TestBondIssMeetPrvtSecPymtTestInd	Change In Use Bond Financed PropChangeInUseBondFinancedPropInd	Procs Nonqualified Bond RemdtdProcsNonqualifiedBondRemdtdInd
A	false	false	Yes (true)	Yes (true)	Yes (true)	Yes (true)	false	false	Yes (true)
B	false	false	false		Yes (true)	Yes (true)	false	false	Yes (true)
C	false	false	Yes (true)	Yes (true)	Yes (true)	Yes (true)	false	false	Yes (true)
D	false	false	Yes (true)	Yes (true)	Yes (true)	Yes (true)	false	false	Yes (true)

Tax Exempt Bonds Arbitrage TaxExemptBondsArbitrageGrp (4 entries)

Bond ReferenceBondReferenceCd	Form8038 T FiledForm8038TFiledInd	Rebate Not Due YetRebateNotDueYetInd	Exception To RebateExceptionToRebateInd	No Rebate DueNoRebateDueInd	Variable Rate IssueVariableRateIssueInd	Hedge Identified In Bks And RecHedgeIdentifiedInBksAndRecInd	Term Of HedgeTermOfHedgePct	Superintegrated HedgeSuperintegratedHedgeInd	Hedge TerminatedHedgeTerminatedInd	Gross Proceeds Invested In GICGrossProceedsInvestedInGICInd	Gross Proceeds InvestedGrossProceedsInvestedInd	Written Proc To Monitor ReqsWrittenProcToMonitorReqsInd
MORGAN STANLEY CAPITAL SERVICES INC
A	false	false	false	Yes (true)	Yes (true)	Yes (true)	39.8	false	false	false	false	Yes (true)
(no name)
B	false	false	false	Yes (true)	false	false				false	false	Yes (true)
(no name)
C	false	false	false	Yes (true)	false	false				false	false	Yes (true)
MORGAN STANLEY CAPITAL SERVICES INC
D	false	false	Yes (true)	false	Yes (true)	Yes (true)	39.8	false	false	false	false	Yes (true)

Procedures Corrective Action ProceduresCorrectiveActionGrp (4 entries)

Bond ReferenceBondReferenceCd	Procedures Corrective ActionProceduresCorrectiveActionInd
A	Yes (true)
B	Yes (true)
C	Yes (true)
D	Yes (true)

Supplemental Information Detail SupplementalInformationDetail (6 entries)

Form And Line ReferenceFormAndLineReferenceDesc	ExplanationExplanationTxt
Schedule K, Part I, Column (f) B (F) DESCRIPTION OF PURPOSE	THE BOND ISSUE WAS USED TO PARTIALLY COVER THE ACQUISITION AND FIT-OUT OF RESEARCH SPACE AND VIVARIUM AT THE LONGWOOD CENTER; TO PARTIALLY COVER THE REPLACEMENT OF HVAC SYSTEM AT THE SMITH BUILDING; TO COVER THE RELOCATION TO, RECONSTRUCTION AND EQUIPPING OF THE INSTITUTE'S CELL MANIPULATION CORE FACILITY; AND TO COVER THE COSTS OF BOND ISSUANCE AND INTEREST DURING THE CONSTRUCTION PERIOD AS WELL AS OTHER CAPITAL PROJECTS.
Schedule K, Part II (PROCEEDS)	B 3 THE TOTAL PROCEEDS OF $282,914,006 INCLUDE INVESTMENT EARNINGS IN THE AMOUNT OF $1,127,526.
Schedule K, Part IV SCHEDULE K, PART IV (ARBITRAGE)	D 2(b) This issuance was refunded in 2021 and had no invested assets and qualifies for 6-month spending exception. E 2(b) This issuance was refunded in 2021 and had no invested assets and qualifies for 6-month spending exception.
Schedule K, Part IV, Line 2c COLUMN A	Issuer name: MASSACHUSETTS DEVELOPMENT FINANCE AGENCY The calculation for computing no rebate due was performed on 11/01/2020
Schedule K, Part IV, Line 2c COLUMN B	Issuer name: MASSACHUSETTS DEVELOPMENT FINANCE AGENCY The calculation for computing no rebate due was performed on 11/01/2020
Schedule K, Part IV, Line 2c COLUMN C	Issuer name: MASSACHUSETTS DEVELOPMENT FINANCE AGENCY The calculation for computing no rebate due was performed on 11/01/2020

Schedule K IRS990ScheduleK

Tax Exempt Bonds Issues TaxExemptBondsIssuesGrp

Field	Value	IRS element (for citing)
Bond Reference	A	BondReferenceCd

Issuer Name IssuerName

Field	Value	IRS element (for citing)
Business Name Line1	MASSACHUSETTS DEVELOPMENT FINANCE AGENCY	BusinessNameLine1Txt

Field	Value	IRS element (for citing)
Bond Issuer EIN	043431814	BondIssuerEIN
Bond Issued	2021-07-28	BondIssuedDt
Issue Price	$35,000,000	IssuePriceAmt
Purpose	THE BOND ISSUE WAS USED TO REFUND SERIES L-2B BONDS ISSUED ON 7/2/2012.	PurposeDesc
Defeased	false	DefeasedInd
On Behalf Of Issuer	false	OnBehalfOfIssuerInd
Pool Financing	false	PoolFinancingInd

Tax Exempt Bonds Proceeds TaxExemptBondsProceedsGrp

Field	Value	IRS element (for citing)
Bond Reference	A	BondReferenceCd
Total Proceeds	$35,000,000	TotalProceedsAmt
Other Spent Proceeds	$35,000,000	OtherSpentProceedsAmt
Substantial Completion	2021	SubstantialCompletionYr
Refunding Tax Exempt Bonds	Yes (true)	RefundingTaxExemptBondsInd
Refunding Taxable Bonds	false	RefundingTaxableBondsInd
Final Allocation Made	Yes (true)	FinalAllocationMadeInd
Adequate Books And Rec Maint	Yes (true)	AdequateBooksAndRecMaintInd

Tax Exempt Bonds Private Bus Use TaxExemptBondsPrivateBusUseGrp

Field	Value	IRS element (for citing)
Bond Reference	A	BondReferenceCd
Owning Bond Financed Property	false	OwningBondFinancedPropertyInd
Any Lease Arrangements	false	AnyLeaseArrangementsInd
Mgmt Contract Bond Fincd Prop	Yes (true)	MgmtContractBondFincdPropInd
Engage Bond Counsel Contracts	Yes (true)	EngageBondCounselContractsInd
Any Research Agreements	Yes (true)	AnyResearchAgreementsInd
Engage Bond Counsel Research	Yes (true)	EngageBondCounselResearchInd
Private Bus Use By Others	0.0	PrivateBusUseByOthersPct
Private Bus Concerning UBI	0.0	PrivateBusConcerningUBIPct
Total Private Business Use	0.0	TotalPrivateBusinessUsePct
Bond Iss Meet Prvt Sec Pymt Test	false	BondIssMeetPrvtSecPymtTestInd
Change In Use Bond Financed Prop	false	ChangeInUseBondFinancedPropInd
Procs Nonqualified Bond Remdtd	Yes (true)	ProcsNonqualifiedBondRemdtdInd

Tax Exempt Bonds Arbitrage TaxExemptBondsArbitrageGrp

Field	Value	IRS element (for citing)
Bond Reference	A	BondReferenceCd
Form8038 T Filed	false	Form8038TFiledInd
Rebate Not Due Yet	false	RebateNotDueYetInd
Exception To Rebate	Yes (true)	ExceptionToRebateInd
No Rebate Due	false	NoRebateDueInd
Variable Rate Issue	Yes (true)	VariableRateIssueInd
Hedge Identified In Bks And Rec	Yes (true)	HedgeIdentifiedInBksAndRecInd

Hedge Provider Name HedgeProviderName

Field	Value	IRS element (for citing)
Business Name Line1	MORGAN STANLEY CAPITAL SERVICES INC	BusinessNameLine1Txt

Field	Value	IRS element (for citing)
Term Of Hedge	39.8	TermOfHedgePct
Superintegrated Hedge	false	SuperintegratedHedgeInd
Hedge Terminated	false	HedgeTerminatedInd
Gross Proceeds Invested In GIC	false	GrossProceedsInvestedInGICInd
Gross Proceeds Invested	false	GrossProceedsInvestedInd
Written Proc To Monitor Reqs	Yes (true)	WrittenProcToMonitorReqsInd

Procedures Corrective Action ProceduresCorrectiveActionGrp

Field	Value	IRS element (for citing)
Bond Reference	A	BondReferenceCd
Procedures Corrective Action	Yes (true)	ProceduresCorrectiveActionInd

Schedule L IRS990ScheduleL

Loans Btwn Org Interested Prsn LoansBtwnOrgInterestedPrsnGrp (3 entries)

Relationship With OrgRelationshipWithOrgTxt	Loan PurposeLoanPurposeTxt	Loan From OrganizationLoanFromOrganizationInd	Original PrincipalOriginalPrincipalAmt	Balance DueBalanceDueAmt	DefaultDefaultInd	Board Or Committee ApprovalBoardOrCommitteeApprovalInd	Written AgreementWrittenAgreementInd
Melany Duval
Employee	Housing Loan	Yes (X)	$150,000	$63,750	false	Yes (true)	Yes (true)
Kevin Haigis
Employee	Housing Loan	Yes (X)	$100,000	$55,834	false	Yes (true)	Yes (true)
Jennifer Willcox
Employee	Tuition Assistance	Yes (X)	$73,000	$72,392	false	Yes (true)	Yes (true)

Field	Value	IRS element (for citing)
Total Balance Due	$191,976	TotalBalanceDueAmt

Schedule M IRS990ScheduleM

Clothing And Household Goods ClothingAndHouseholdGoodsGrp

Field	Value	IRS element (for citing)
Non Cash Checkbox	Yes (X)	NonCashCheckboxInd
Noncash Contributions Rpt F990	$1,726,800	NoncashContributionsRptF990Amt
Method Of Determining Revenues	Other	MethodOfDeterminingRevenuesTxt

Cars And Other Vehicles CarsAndOtherVehiclesGrp

Field	Value	IRS element (for citing)
Non Cash Checkbox	Yes (X)	NonCashCheckboxInd
Contribution	48	ContributionCnt
Noncash Contributions Rpt F990	$111,952	NoncashContributionsRptF990Amt
Method Of Determining Revenues	Other - Fair Market Value	MethodOfDeterminingRevenuesTxt

Securities Closely Held Stock SecuritiesCloselyHeldStockGrp

Field	Value	IRS element (for citing)
Non Cash Checkbox	Yes (X)	NonCashCheckboxInd
Contribution	283	ContributionCnt
Noncash Contributions Rpt F990	$29,897,031	NoncashContributionsRptF990Amt
Method Of Determining Revenues	Other - FAIR MARKET VALUE	MethodOfDeterminingRevenuesTxt

Food Inventory FoodInventoryGrp

Field	Value	IRS element (for citing)
Non Cash Checkbox	Yes (X)	NonCashCheckboxInd
Contribution	16	ContributionCnt
Noncash Contributions Rpt F990	$85,203	NoncashContributionsRptF990Amt
Method Of Determining Revenues	Other - MARKET VALUE PER DONOR	MethodOfDeterminingRevenuesTxt

Other Non Cash Contri Table OtherNonCashContriTableGrp (3 entries)

Non Cash CheckboxNonCashCheckboxInd	DescDesc	ContributionContributionCnt	Noncash Contributions Rpt F990NoncashContributionsRptF990Amt	Method Of Determining RevenuesMethodOfDeterminingRevenuesTxt
Yes (X)	EQUIPMENT	2	$547,066	Other - MARKET VALUE PER DONOR
Yes (X)	EVENT TICKETS	9	$769,459	Other - MARKET VALUE PER DONOR
Yes (X)	MISCELLANEOUS	1	$3,000	Other - MARKET VALUE PER DONOR

Field	Value	IRS element (for citing)
Any Property That Must Be Held	false	AnyPropertyThatMustBeHeldInd
Review Process Unusual NC Gifts	Yes (true)	ReviewProcessUnusualNCGiftsInd
Third Parties Used	Yes (true)	ThirdPartiesUsedInd

Supplemental Information Detail SupplementalInformationDetail (3 entries)

Form And Line ReferenceFormAndLineReferenceDesc	ExplanationExplanationTxt
Schedule M, Part I COLUMN (B)	DANA-FARBER CANCER INSTITUTE, INC. (DFCI) REPORTING THE NUMBER OF CONTRIBUTIONS RECEIVED.
Schedule M, Part I, Line 32b Third parties used to solicit, process, or sell noncash contributions	DFCI HAS AN ARRANGEMENT WITH ANOTHER CHARITY PURSUANT TO WHICH THE OTHER CHARITY ACCEPTS CERTAIN NONCASH DONATIONS FOR THE BENEFIT OF DANA-FARBER. PROCEEDS FROM THE SALE OF NONCASH DONATIONS ARE DIRECTED TO A DESIGNATED FUND FOR THE BENEFIT OF DANA-FARBER. IN ADDITION, DANA-FARBER HAS AN ARRANGEMENT WITH ANOTHER CHARITY PURSUANT TO WHICH THE OTHER CHARITY PROCESSES VEHICLE DONATIONS FOR THE BENEFIT OF DANA-FARBER. PROCEEDS FROM THE SALE OF DONATED VEHICLES ARE DIRECTED TO DANA-FARBER.
Schedule M, Part I, Line 33 Noncash contribution amounts not reported	DFCI RECEIVED DONATIONS OF ART, BOOKS, AND OTHER GOODS THAT IT DISPLAYS IN ITS PROPERTIES. THESE GOODS HAVE VALUES THAT ARE EITHER NOMINAL OR ARE NOT READILY DETERMINABLE AND ARE, THEREFORE, NOT INCLUDED AS REVENUE.

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (13 entries)

Form And Line ReferenceFormAndLineReferenceDesc	ExplanationExplanationTxt
Form 990, Part I, Line 1 Organization's mission	THE MISSION OF DANA-FARBER CANCER INSTITUTE (DFCI) IS TO PROVIDE EXPERT, COMPASSIONATE, AND EQUITABLE CARE TO CHILDREN, ADULTS, AND THEIR FAMILIES, WHILE ADVANCING THE UNDERSTANDING, DIAGNOSIS, TREATMENT, CURE, AND PREVENTION OF CANCER AND RELATED DISEASES. WE TRAIN NEW GENERATIONS OF CLINICIANS AND SCIENTISTS, DISSEMINATE INNOVATIVE PATIENT THERAPIES AND SCIENTIFIC DISCOVERIES AROUND THE WORLD, AND REDUCE THE IMPACT OF CANCER, WHILE AT ALL TIMES MAINTAINING A FOCUS ON THOSE COMMUNITIES THAT HAVE BEEN HISTORICALLY MARGINALIZED.
Form 990, Part III, Line 1 Organization's mission	THE MISSION OF DFCI IS TO PROVIDE EXPERT, COMPASSIONATE, AND EQUITABLE CARE TO CHILDREN, ADULTS, AND THEIR FAMILIES, WHILE ADVANCING THE UNDERSTANDING, DIAGNOSIS, TREATMENT, CURE, AND PREVENTION OF CANCER AND RELATED DISEASES. WE TRAIN NEW GENERATIONS OF CLINICIANS AND SCIENTISTS, DISSEMINATE INNOVATIVE PATIENT THERAPIES AND SCIENTIFIC DISCOVERIES AROUND THE WORLD, AND REDUCE THE IMPACT OF CANCER, WHILE AT ALL TIMES MAINTAINING A FOCUS ON THOSE COMMUNITIES THAT HAVE BEEN HISTORICALLY MARGINALIZED.
Form 990, Part III, Line 4a Program Service Accomplishments	CLINICAL CARE As one of the leading cancer centers in the world, Dana-Farber Cancer Institute provides compassionate, comprehensive, and personalized care to adults and children with cancer, blood disorders, and related diseases. In fiscal year 2024, our expert clinicians and caregivers at our specialized treatment centers worked together to deliver the latest therapies to our patients through 1,299 inpatient admissions, 398,705 outpatient doctor visits, and 229,653 infusion treatments. Since its founding in 1947 by Sidney Farber, MD, Dana-Farber has followed his vision for a cancer center that is just as dedicated to discoveries in cancer research as it is to delivering expert, compassionate care. Our Institute is a founding member of Dana-Farber/Harvard Cancer Center and one of 57 NCI-designated Comprehensive Cancer Centers in the U.S., we are the only hospital ranked in the top four nationally by U.S. News and World Report in both adult and pediatric cancer care. In 2024, we offered more than 1,100 clinical trials.
Form 990, Part III, Line 4b Program Service Accomplishments	RESEARCH Scientific work at Dana-Farber is based on the premise that basic and clinical investigation are complementary and reinforcing activities. To encourage this cross-pollination of ideas, the Institute has developed an organizational framework that fosters collaborations among investigators from different disciplines. The result is an intense scientific impact on a group of diseases that continue to represent one of humanity's greatest health challenges. Some recent advances include: PARP inhibitor showed long term survival benefits for patients with high-risk breast cancer: In a large phase 3 multicenter clinical trial, patients with BRCA-positive breast cancer who received a PARP inhibitor called olaparib after standard treatment had better survival outcomes than those who received placebo, reported Dana-Farber researchers. CDK4/6 inhibitor benefitted patients with HR+, HER2+ breast cancer: Adding a CDK4/6 inhibitor to standard therapy for patients with "double positive" metastatic breast cancer improved progression-free survival in a phase 3 clinical trial, reported Dana-Farber investigators. A mismatched unrelated donor achieves the same outcomes as a fully matched donor for allogeneic stem cell transplant: Dana-Farber researchers found that a mismatched unrelated donor can be used safely and achieve the same outcomes as a fully-matched donor as long as seven of the eight human leukocyte antigen (HLA) variables - genetic variables that dictate how the immune system communicates - are matched and post-transplant cyclophosphamide follows infusion of the stem-cell graft. This approach increases the probability of finding a donor to 75 to 95% for any ethnicity. Rapid blood cancer diagnostic could speed decisions: Dana-Farber researchers created a molecular diagnostic that rapidly detects genetic mutations that are used to guide treatment of two forms of leukemia, enabling more patients with these blood cancers to receive lifesaving cancer treatments in a timely manner. This accessible rapid test could prevent life threatening treatment delays. Potential marker of aging and breast cancer risk discovered: As humans age, expression levels of a gene called midkine ratchet upward. Dana-Farber investigators found that as levels of midkine increase, so does the likelihood of breast cancer in animal studies. The findings could lead to possible strategies for lowering the risk of breast cancer. Cellular refueling process repurposed to fight cancer: Dana-Farber researchers described the bioengineering behind a new platform for potential cancer therapy that turns a rapid cellular refueling system into a protein degradation mechanism. The system uses a bispecific antibody to bind a disease-causing membrane protein of interest to the refueling system, and the refueling system pulls the disease-causing protein into the cell, where it is destroyed. CDK4/6 inhibitors showed promise for adolescent glioma subtype: Dana-Farber researchers discovered that a subtype of high-grade gliomas that occurs during adolescence is vulnerable to CDK4/6 inhibitors. A global clinical trial is planned to test ribociclib, a CDK4/6 inhibitor, in patients with a high-grade glioma subtype. Antibody-drug conjugate found effective against brain metastases in patients with HER2+ breast cancer: Trastuzumab deruxtecan showed substantial anti-cancer activity in brain metastases in patients with HER2+ breast cancer according to an international clinical trial led by Dana-Farber researchers. The U.S. Food and Drug Administration approved kidney cancer therapy based on evidence from Dana-Farber research: Belzutifan, a HIF-2alpha inhibitor, was approved based on results of a clinical trial led by Dana-Farber showing that belzutifan significantly reduced the risk of progression of clear cell renal cell carcinoma compared to everolimus. Dana-Farber investigators discovered the role of HIF-2alpha in cancer. The U.S. Food and Drug Administration approved new therapy for glioma patients: For the first time in decades, a new drug, vorasidenib, was approved for patients with grade 2 IDH-mutant glioma after surgery based on a phase 3 clinical trial co-led by Dana-Farber investigators. The trial found that vorasidenib more than doubled progression-free survival and delayed the need for radiation and chemotherapy. Anti-inflammatory drug could reduce risk of colon cancer recurrence in certain patients: A Dana-Farber analysis of data from a phase 3 clinical trial found that patients with PIK3Ca mutations who took the anti-inflammatory drug celecoxib after surgery had longer overall and disease-free survival than those without the mutation. Antibody-drug conjugate highly effective in preventing recurrence in early stage HER2+ breast cancer: In a Dana-Farber led clinical trial of patients with stage 1 HER2+ breast cancer, treatment with trastuzumab emtansine after surgery improved disease-free survival compared to treatment with trastuzumab. Radioligand therapy favored after progression on hormone therapy for metastatic prostate cancer: A Dana-Farber led follow-on study of results from the pivotal PSMAFore clinical trial found that radioligand therapy improved progression-free survival for patients who had progressed on an androgen receptor pathway inhibitor compared to a change in androgen receptor pathway inhibition therapy. A novel target for pediatric neuroblastoma discovered: Dana-Farber research identified a novel approach to treatment of MYCN-amplified neuroblastoma, a high-risk form of the most common childhood solid tumor. They discovered that the cancer has a dependence on the SAGA Complex, an epigenetic regulator that they also found can be inhibited pharmacologically.
Form 990, Part III, Line 4c Program service accomplishments	COMMUNITY HEALTH The role of Dana-Farber's Community Health office is to support the Institute's goal to reduce cancer risk among medically underserved populations. We work with city and state health departments, community partners, and Boston-based coalitions to assess and monitor the needs of local residents with respect to cancer control. In collaboration with staff throughout Dana-Farber, we serve as a bridge with community organizations and establish evidence-based and sustainable outreach programs. We are on the front lines of supporting and collaborating on programs designed to eliminate disparities in breast, colon, and skin cancer; educate diverse populations about tobacco cessation, human papillomavirus (HPV) prevention and screening; and strengthen the support system for medically underserved populations. In short, we are committed to making Dana-Farber's care and research findings more accessible to everyone within and outside its walls. FY24 programmatic highlights are as follows: Dana-Farber's mammography services provided 2,642 mammograms on the van and at the mammography suite at Whittier Street Health Center in Roxbury. Dana-Farber's Sun Safety Program provided 17 in-person sun safety screening events with added health and safety measures. 884 participants were screened by a dermatologist and 104 people were referred for follow-up appointments. 54 participants were referred for a biopsy. Dana-Farber's Tobacco Treatment program received 103 referrals and provided 76 individual tobacco cessation counseling sessions to 27 patients. 24 participants were able to reduce their total number of cigarettes smoked per day, and 12 of these reported being able to quit completely. The Tobacco Treatment program continued to provide financial incentives for participants enrolled in the program. Stop and Shop gift cards were provided after counseling sessions to encourage individuals to reduce their tobacco usage and quit smoking. Launched AssessYourRisk, a digital tool to help women of all ages assess and manage their breast and ovarian cancer risk. Dana-Farber implemented and evaluated the third year of Dana-Farber's multi-year Systems Level Funding, awarded to four non-profit organizations in Greater Boston to address environmental justice, food insecurity, and child homelessness. Successes from the third year include raising awareness, building resident power, and gathering evidence for advocacy in pursuit of creating meaningful policy, systems and environmental (PSE) change. The Community Health Office hired and trained a new bilingual Community Outreach Specialist fluent in Haitian Creole. The Education and Outreach team held 44 events in 4 languages (English, Spanish, Cantonese and Mandarin), reaching a total of 3,550 participants. This included cancer education sessions hosted with partner organizations and tabling at community events serving historically marginalized populations. The Community Health Office also worked with DFCI guest speakers to bring new topics to the community, including Palliative Care & Mental Health and Family History & Genetics. The Education and Outreach team expanded outreach in Chinese and Spanish media by sharing cancer prevention information and events on new WeChat platform and organized interviews with Dana-Farber staff for cancer awareness months on Spanish Media platforms like El Mundo.
Form 990, Part VI, Line 2 Family/business relationships amongst interested persons	ANDREW JANOWER AND MICHAEL EISENSON - Business relationship, JOSH BEKENSTEIN, ANDREW KAPLAN, AND NANCY LOTANE - Business relationship, PHILLIP GROSS AND DEMOND MARTIN - Business relationship, RICHARD LUBIN, CHRISTOPHER HADLEY, AND JANE BROCK-WILSON - Business relationship, SUSHIL TULI AND PETER PALANDJIAN - Business relationship, BRIAN KNEZ AND JESSICA KNEZ DULAC - Family relationship, JOHN O'CONNOR AND LAURA SEN - Family relationship
Form 990, Part VI, Line 11b Review of form 990 by governing body	THE DFCI'S TAX DEPARTMENT PROVIDES ALL FINANCIAL ANALYSIS AND OTHER INFORMATION TO BE INCLUDED ON THE TAX RETURN TO ITS EXTERNAL TAX PREPARER, ERNST & YOUNG LLP, WHICH PREPARES THE DRAFT RETURN. THE DRAFT RETURN IS THEN REVIEWED BY THE DFCI'S TAX MANAGER, AS WELL AS THE DFCI'S OFFICE OF GENERAL COUNSEL AND SENIOR MANAGEMENT, BEFORE IT IS SUBMITTED FOR AUDIT COMMITTEE REVIEW. AFTER THE AUDIT COMMITTEE REVIEWS THE TAX RETURN, AN ELECTRONIC MESSAGE IS SENT TO ALL GOVERNING BOARD MEMBERS WITH A SECURE LINK TO THE TAX RETURN. THE BOARD HAS THE OPPORTUNITY TO REVIEW THE RETURN AND BRING ANY ISSUES TO THE ATTENTION OF THE APPROPRIATE EXECUTIVE MANAGEMENT INDIVIDUALS. A FINAL VERSION OF THE FORM IS APPROVED BY THE CFO AND FILED ELECTRONICALLY BY ERNST & YOUNG LLP WITH THE IRS.
Form 990, Part VI, Line 12c Conflict of interest policy	DFCI MONITORS AND ENFORCES COMPLIANCE WITH THE DFCI CONFLICT OF INTEREST AND CONFIDENTIALITY POLICY FOR BOARD OFFICERS, TRUSTEES, AND KEY EMPLOYEES ("COVERED PERSONS"). THE OFFICE OF GENERAL COUNSEL ANNUALLY DISTRIBUTES A CONFLICT OF INTEREST QUESTIONNAIRE AND CONFIDENTIALITY STATEMENT ("STATEMENT") REQUIRING ALL COVERED PERSONS TO DISCLOSE INTERESTS, ROLES, AND ACTIVITIES THAT COULD GIVE RISE TO A POTENTIAL OR ACTUAL CONFLICT WITH THE INTERESTS OF DFCI. IF A TRUSTEE FAILS TO COMPLETE THE ANNUAL STATEMENT, THE CHAIR OF THE GOVERNANCE COMMITTEE MAY TAKE ACTIONS TO SUSPEND THE TRUSTEE. ADDITIONALLY, DFCI REQUIRES COVERED PERSONS TO COMPLETE THE STATEMENT UPON INITIAL APPOINTMENT TO A COVERED OFFICE AND TO UPDATE THEIR DISCLOSURES ON A CONTINUING BASIS WHENEVER A COVERED PERSON BECOMES AWARE OF A NEW OR PREVIOUSLY UNDISCLOSED INTEREST. THE OFFICE OF GENERAL COUNSEL COMPARES THE DISCLOSURES TO INSTITUTIONAL INFORMATION IN ORDER TO IDENTIFY POTENTIAL OR ACTUAL CONFLICTS OF INTEREST. THE DFCI GENERAL COUNSEL REPORTS ON ALL DISCLOSURES TO THE PRESIDENT OF DFCI, CHAIR OF THE DFCI BOARD AND CHAIR OF THE DFCI BOARD GOVERNANCE COMMITTEE. THE BOARD IS RESPONSIBLE UNDER THE COI POLICY FOR ADDRESSING ISSUES RELATED TO CONFLICTS OF COVERED PERSONS. A PROPOSED ARRANGEMENT CREATING A CONFLICT OF INTEREST MAY BE APPROVED IF APPROPRIATE STEPS ARE TAKEN TO ENSURE THAT DFCI MAKES A DECISION IN AN OBJECTIVE AND FAIR MANNER CONSISTENT WITH THE HIGHEST ETHICAL AND LEGAL STANDARDS. SUCH STEPS INCLUDE RECUSAL OF THE COVERED PERSON WITH A CONFLICT OF INTEREST FROM NEGOTIATIONS OR DISCUSSIONS ON BEHALF OF DFCI OR THE ENTITY WITH WHICH DFCI IS DOING BUSINESS AND FROM BOARD OR DFCI MANAGEMENT DISCUSSIONS OF SUCH ARRANGEMENT.
Form 990, Part VI, Line 15a Process to establish compensation of top management official	PER DFCI'S EXECUTIVE COMPENSATION PHILOSOPHY, ANNUALLY THE COMPENSATION COMMITTEE OF THE BOARD OF TRUSTEES REVIEWS THE PRESIDENT'S (DFCI'S CHIEF EXECUTIVE OFFICER) PERFORMANCE AND MAKES A RECOMMENDATION REGARDING COMPENSATION TO THE EXECUTIVE COMMITTEE. THE EXECUTIVE COMMITTEE ACTS ON THE RECOMMENDATION. TO ENSURE COMPLIANCE WITH THE PHILOSOPHY, THE COMPENSATION COMMITTEE ANNUALLY COMMISSIONS AN INDEPENDENT REVIEW BY A THIRD-PARTY EXECUTIVE COMPENSATION CONSULTANT TO COMPARE SUCH COMPENSATION WITH THAT OF OTHER SIMILARLY SITUATED INDIVIDUALS IN THE HEALTHCARE FIELD IN AND OUTSIDE OF THE REGION. THE DECISION OF THE EXECUTIVE COMMITTEE IS REPORTED TO THE FULL BOARD. THE BOARD COMPLETED THIS PROCESS AS OF JANUARY 2023.
Form 990, Part VI, Line 15b Process to establish compensation of other employees	PROCESS FOR DETERMINING COMPENSATION OF OFFICERS AND KEY EMPLOYEES PER DFCI'S EXECUTIVE COMPENSATION PHILOSOPHY, ANNUALLY THE DFCI PRESIDENT REVIEWS THE PERFORMANCE OF OFFICERS AND KEY EMPLOYEES. THE PRESIDENT MAKES A RECOMMENDATION AS TO THE COMPENSATION OF THOSE INDIVIDUALS WHO ARE DISQUALIFIED PERSONS OF DFCI TO THE COMPENSATION COMMITTEE OF THE BOARD OF TRUSTEES. THE COMPENSATION COMMITTEE APPROVES COMPENSATION FOR THOSE INDIVIDUALS BASED ON THAT RECOMMENDATION. FOR KEY EMPLOYEES WHO ARE NOT DISQUALIFIED PERSONS, THE PRESIDENT REPORTS TO THE COMPENSATION COMMITTEE OF THE BOARD OF TRUSTEES ON HER DETERMINATION OF COMPENSATION FOR THOSE INDIVIDUALS. TO ENSURE COMPLIANCE WITH THE PHILOSOPHY, THE PRESIDENT AND COMPENSATION COMMITTEE ANNUALLY RECEIVE A REPORT BY A THIRD-PARTY EXECUTIVE COMPENSATION CONSULTANT. THE REPORT ANALYZES THE COMPETITIVENESS OF THE TOTAL COMPENSATION PROGRAM FOR DISQUALIFIED PERSONS AGAINST MARKET DATA REPRESENTING DFCI'S LOCAL AND NATIONAL PEER ORGANIZATIONS. THE PRESIDENT MAKES RECOMMENDATIONS FOR MARKET ADJUSTMENTS AS NEEDED FOR THOSE INDIVIDUALS WHO ARE DISQUALIFIED PERSONS OF DFCI TO THE COMPENSATION COMMITTEE OF THE BOARD OF TRUSTEES. THE COMPENSATION COMMITTEE APPROVES MARKET ADJUSTMENTS FOR THOSE INDIVIDUALS BASED ON THE PRESIDENT'S RECOMMENDATION. THE BOARD COMPLETED THIS PROCESS AS OF JUNE 2023. FOR KEY EMPLOYEES WHO ARE NOT DISQUALIFIED PERSONS, THE PRESIDENT REPORTS TO THE COMPENSATION COMMITTEE OF THE BOARD OF TRUSTEES ON HER DETERMINATION OF MARKET ADJUSTMENTS AS NEEDED FOR THOSE INDIVIDUALS.
Form 990, Part VI, Line 19 Required documents available to the public	GOVERNING DOCUMENTS: THE GOVERNING DOCUMENTS ARE AVAILABLE UPON REQUEST. THESE DOCUMENTS ARE ALSO AVAILABLE TO THE PUBLIC ON THE SECRETARY OF THE COMMONWEALTH'S WEBSITE. CONFLICT OF INTEREST POLICY: DFCI'S BOARD OF TRUSTEES CONFLICT OF INTEREST POLICY IS AVAILABLE UPON REQUEST. FINANCIAL STATEMENTS: THE ORGANIZATION USES THE SERVICES OF DIGITAL ASSURANCE CERTIFICATION LLC (DAC) TO REPORT ANNUAL AUDITED FINANCIAL STATEMENTS AND OTHER RELEVANT ORGANIZATIONAL INFORMATION AS REQUIRED BY CERTAIN REGULATORY AND TAX LAWS. DAC IS A WEBSITE (WWW.DACBOND.COM) FREE TO THE PUBLIC THAT PUBLISHES TAX-EXEMPT BOND ISSUERS' FINANCIAL AND LEGAL DOCUMENTS SUCH AS THE AUDITED FINANCIAL STATEMENTS. FISCAL YEAR 2016 THROUGH THE LATEST ISSUE DATE OF THE AUDITED FINANCIAL STATEMENTS FOR DANA-FARBER CANCER INSTITUTE, INC. CAN BE FOUND ON THE DAC WEBSITE. ANNUAL AUDITED FINANCIAL STATEMENTS FROM FISCAL YEAR 1998 THROUGH FISCAL YEAR 2015 ARE AVAILABLE UPON REQUEST.
Form 990, Part VIII, Line 11d Other Miscellaneous Revenue	- Total Revenue: 2962972, Related or Exempt Function Revenue: , Unrelated Business Revenue: 41707, Revenue Excluded from Tax Under Sections 512, 513, or 514: 2921265;
Form 990, Part XI, Line 9 Other changes in net assets or fund balances	CHANGE IN INTEREST IN ASSETS HELD BY AFFILIATES - XXX-XX-XXXX; CHANGE IN VALUE OF SWAP AGREEMENT - -36707389; PENSION ADJUSTMENT - 880349;

Schedule R IRS990ScheduleR

Id Disregarded Entities IdDisregardedEntitiesGrp (3 entries)

Address Line1USAddress/AddressLine1Txt	Address Line2USAddress/AddressLine2Txt	CityUSAddress/CityNm	State AbbreviationUSAddress/StateAbbreviationCd	ZIPUSAddress/ZIPCd	EINEIN	Primary ActivitiesPrimaryActivitiesTxt	Legal Domicile StateLegalDomicileStateCd	Total IncomeTotalIncomeAmt	End Of Year AssetsEndOfYearAssetsAmt	Business Name Line1DirectControllingEntityName/BusinessNameLine1Txt
DANA-FARBER GLOBAL ONCOLOGY LLC
450 BROOKLINE AVENUE	BP418	BOSTON	MA	02215	851914853	INTERNATIONAL ONCOLOGY	MA	$182,940	$7,805,851	DFCI
BINNEY STREET CAPITAL FUND LLC
450 BROOKLINE AVENUE	BP418	BOSTON	MA	02215		INVESTMENTS	DE	-$1,246,580	$6,817,920	DFI
Dana-Farber National Workforce LLC
450 BROOKLINE AVENUE	BP418	BOSTON	MA	02215	921748999	Professional employer organization	MA	$0	$0	DFCI

Id Related Tax Exempt Org IdRelatedTaxExemptOrgGrp (7 entries)

Address Line1USAddress/AddressLine1Txt	Address Line2USAddress/AddressLine2Txt	CityUSAddress/CityNm	State AbbreviationUSAddress/StateAbbreviationCd	ZIPUSAddress/ZIPCd	EINEIN	Primary ActivitiesPrimaryActivitiesTxt	Legal Domicile StateLegalDomicileStateCd	Exempt Code SectionExemptCodeSectionTxt	Public Charity StatusPublicCharityStatusTxt	Business Name Line1DirectControllingEntityName/BusinessNameLine1Txt	Controlled OrganizationControlledOrganizationInd
DANA-FARBER INC
450 BROOKLINE AVENUE	BP418	BOSTON	MA	02215	043102433	INVESTMENT MANAGEMENT	MA	501(c)(3)	Type I	DFCI	Yes (true)
THE DANA-FARBER TRUST INC
450 BROOKLINE AVENUE	BP418	BOSTON	MA	02215	300195757	RECEIVE REAL ESTATE GIFTS FOR DFCI	MA	501(c)(3)	Type I	DFCI	Yes (true)
DANA-FARBERMASS GEN BRIGHAM CANCER CARE
450 BROOKLINE AVENUE	BP418	BOSTON	MA	02215	043320640	ONCOLOGY RESEARCH	MA	501(c)(3)	Type I	NA	false
RMSA TRUST
450 BROOKLINE AVENUE	BP418	BOSTON	MA	02215	562656539	VEBA TRUST	MA	501(c)(9)		DFCI	Yes (true)
FRIENDS OF DANA-FARBER CANCER INSTITUTE
450 BROOKLINE AVENUE	BP418	BOSTON	MA	02215	371613621	FUNDRAISING	MA	501(c)(3)	Type I	DFCI	Yes (true)
DANA-FARBERCHILDREN'S HOSP CANCER CARE
450 BROOKLINE AVENUE	BP418	BOSTON	MA	02215	043554536	PEDIATRIC ONCOLOGY	MA	501(c)(3)	Type I	NA	false
DANA-FARBER CANCER CARE NETWORK INC
450 BROOKLINE AVENUE	BP418	BOSTON	MA	02215	465138314	ONCOLOGY CARE	MA	501(c)(3)	10	DFCI	Yes (true)

Id Related Org Txbl Partnership IdRelatedOrgTxblPartnershipGrp

Related Organization Name RelatedOrganizationName

Field	Value	IRS element (for citing)
Business Name Line1	MGB DF INTL LLC	BusinessNameLine1Txt

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	399 REVOLUTION DR	AddressLine1Txt
Address Line2	STE 645	AddressLine2Txt
City	SOMERVILLE	CityNm
State Abbreviation	MA	StateAbbreviationCd
ZIP	02145	ZIPCd

Field	Value	IRS element (for citing)
EIN	871595882	EIN
Primary Activities	INTERNATIONAL CONSULTING	PrimaryActivitiesTxt
Legal Domicile State	DE	LegalDomicileStateCd

Direct Controlling Entity Name DirectControllingEntityName

Field	Value	IRS element (for citing)
Business Name Line1	NA	BusinessNameLine1Txt

Field	Value	IRS element (for citing)
Predominant Income Type	N/A	PredominantIncomeTypeTxt
Share Of Total Income	-$2,304	ShareOfTotalIncomeAmt
Share Of EOY Assets	-$144,110	ShareOfEOYAssetsAmt
Disproportionate Allocations	false	DisproportionateAllocationsInd
General Or Managing Partner	false	GeneralOrManagingPartnerInd
Ownership	0.5	OwnershipPct

Field	Value	IRS element (for citing)
Receipt Of Int Annts Rnts Rylts	false	ReceiptOfIntAnntsRntsRyltsInd
Gift Grnt Or Cap Contri To Oth Org	false	GiftGrntOrCapContriToOthOrgInd
Gift Grnt Cap Contri From Oth Org	Yes (true)	GiftGrntCapContriFromOthOrgInd
Loans Or Guarantees To Other Org	false	LoansOrGuaranteesToOtherOrgInd
Loans Or Guarantees From Oth Org	false	LoansOrGuaranteesFromOthOrgInd
Div Related Organization	false	DivRelatedOrganizationInd
Asset Sale To Other Org	false	AssetSaleToOtherOrgInd
Asset Purchase From Other Org	false	AssetPurchaseFromOtherOrgInd
Asset Exchange	false	AssetExchangeInd
Rental Of Facilities To Oth Org	false	RentalOfFacilitiesToOthOrgInd
Rental Of Fclts From Oth Org	false	RentalOfFcltsFromOthOrgInd
Perform Of Services For Oth Org	false	PerformOfServicesForOthOrgInd
Perform Of Services By Other Org	false	PerformOfServicesByOtherOrgInd
Sharing Of Facilities	false	SharingOfFacilitiesInd
Paid Employees Sharing	Yes (true)	PaidEmployeesSharingInd
Reimbursement Paid To Other Org	false	ReimbursementPaidToOtherOrgInd
Reimbursement Paid By Other Org	false	ReimbursementPaidByOtherOrgInd
Transfer To Other Org	Yes (true)	TransferToOtherOrgInd
Transfer From Other Org	Yes (true)	TransferFromOtherOrgInd

Transactions Related Org TransactionsRelatedOrgGrp (5 entries)

Transaction TypeTransactionTypeTxt	InvolvedInvolvedAmt	Method Of Amount DeterminationMethodOfAmountDeterminationTxt
DANA-FARBER INC
S	$395,108,109	Cash
DANA-FARBER INC
R	$102,678,554	Cash
FRIENDS OF DANA-FARBER CANCER INSTITUTE INC
C	$887,893	CASH
FRIENDS OF DANA-FARBER CANCER INSTITUTE INC
O	$325,452	ACTUAL EXP
RMSA Trust
R	$745,126	Cash